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           This prospective, descriptive, cross-sectional, hospital-based 
study aimed to describe the glycemic status of the newborn preterm 
infants who were admitted in the special care baby unit (SCBU) in 
Omdurman Maternity Hospital during the first 72 hours of life. Other 
objectives were to document the prevalence of both hypo and 
hyperglycemic episodes among these infants, as well as to define the 
clinically associated risk factors. Moreover, the study aimed at 
detecting the immediate outcome of these preterm infants in regard to 
their early glycemic status. A total of 82 preterm babies were enrolled 
in the study during the period from June to August 2005. Consent was 
obtained, clinical assessment and a 72 hour-progress were 
documented. Serial determinations of blood glucose were recorded 
using Accu-Check® Active (Roche) device at 1, 2, 6, 12, 18, 24, 36, 48, 
60 and 72 hrs of age. Any abnormal results warranted immediate 
confirmation by the laboratory where the hexokinase enzyme method 
was used to measure the random blood glucose. Data was analyzed 
using the SPSS software computer programme.   
 A total of  734 samples were taken with an average of 8.9 
samples per infant. Of these, hypoglycemia was detected in 46.8%, 
while hyperglycemia was present in 16.6%. Most of these events took 
place during the first 24 hours, thereafter a steady decline was seen. 
Among the whole study group, hyperglycemia was more prevalent 
among the males than in the females, giving a ratio of 1.5:1. The 
frequency of both conditions was  inversely   proportionate to   the   
birth  
weight and the gestational age. Preterm infants who were small for 
gestation (SGA) were the most vulnerable to hypoglycemia which 
occurred in 63.6% of them, and to hyperglycemia which occurred in 
36.6%. Infants born to consanguineous parents had a high percentage 
of hypoglycemia 61.1%. Among maternal medical and obstetrical 
problems, only diabetes mellitus was found to correlate significantly 
with neonatal hypoglycemia. Similarly, maternal pre-medication with 
dextrose infusions was statistically associated with neonatal 
hyperglycemia but not with hypoglycemia.       
            Factors that were found to be  associated with hypoglycemia 
were: delivery by (EMCS), low Apgar score, (RDS), hypothermia, 
intermittent boluses of dextrose and delayed feeding. Factors 
associated with  hyperglycemia were: delivey by (EMCS), low Apgar 
score, administration of aminophylline, intermittent dextrose boluses, 
intraventricular haemorrhage, early sepsis and (DIC). Hypoglycemia 
was reported along the course of 64.3% of the infants who died . 
Hyperglycemia was detected in 42.9% of that cohort. Accordingly, 
hypo and hyperglycemia were both found to be poor prognostic 












            هﺪﻓﺖ هﺬﻩ اﻟﺪراﺳﺔ اﻟﻮﺻﻔﻴﺔ اﻟﻤﺴﺘﻘﺒﻠﻴﺔ ﻋﻠﻲ ﻣﺴﺘﻮي اﻟﻤﺴﺘﺸﻔﻲ، إﻟﻲ وﺻﻒ ﺣﺎﻟﺔ ﻣﺴﺘﻮي 
ﺪي اﻟﻤﻮاﻟﻴﺪ اﻟﺨﺪج ﻓﻲ وﺣﺪة اﻷﻃﻔﺎل ﺣﺪﻳﺜﻲ اﻟﻮﻻدة ﺑﻤﺴﺘﺸﻔﻰ اﻟﻮﻻدة ام درﻣﺎن و ذﻟﻚ ﻓﻲ ﺳﻜﺮ اﻟﺪم ﻟ
ﺑﺎﻹﺿﺎﻓﺔ ﻟﺬﻟﻚ، هﺪﻓﺖ اﻟﺪراﺳﺔ ﻟﻤﻌﺮﻓﺔ ﻣﺪي اﻧﺘﺸﺎر . ﺧﻼل اﻻﺛﻨﺘﻴﻦ و ﺳﺒﻌﻴﻦ ﺳﺎﻋﺔ اﻷوﻟﻲ ﻣﻦ اﻟﺤﻴﺎة
 هﺪﻓﺖ. ﺣﺎﻻت اﻧﺨﻔﺎض و ﻓﺮط ﺳﻜﺮ اﻟﺪم ﻓﻀﻼ ﻋﻦ اآﺘﺸﺎف ﻋﻮاﻣﻞ اﻟﺨﻄﻮرة اﻟﺴﺮﻳﺮﻳﺔ ذات اﻟﺼﻠﺔ
ﺷﻤﻠﺖ .  ﻟﺪراﺳﺔ أﻳﻀﺎ إﻟﻰ وﺻﻒ اﻟﻤﺂﻻت اﻵﻧﻴﺔ ﻟﻠﻤﻮاﻟﻴﺪ اﻟﺨﺪج ذوى اﻻﺿﻄﺮاﺑﺎت ﻓﻲ ﺳﻜﺮ اﻟﺪما
ﺑﻌﺪ أﺧﺬ أﻗﺮار . 5002اﻟﺪراﺳﺔ ﺑﺎﻟﺒﺤﺚ اﺛﻨﻴﻦ و ﺛﻤﺎﻧﻴﻦ وﻟﻴﺪا ﺧﺪﻳﺠﺎ ﻓﻲ اﻟﻔﺘﺮة ﻣﻦ ﻳﻮﻧﻴﻮ إﻟﻲ أﻏﺴﻄﺲ 
 اﻟﺪم و ﺟﻤﻌﺖ ﻋﻴﻨﺎت ﻣﺘﺘﺎﻟﻴﺔ ﻣﻦ.  ﺳﺎﻋﺔ27اﻟﻤﻮاﻓﻘﺔ، ﺗﻢ ﺗﻘﻴﻴﻢ آﻞ ﻃﻔﻞ و ﻣﺘﺎﺑﻌﺘﻪ ﺳﺮﻳﺮﻳﺎ ﻋﻠﻰ ﻣﺪى 
 ﻣﻦ اﻟﻌﻤﺮ و ﺗﻢ ﺗﺤﻠﻴﻠﻬﺎ ﺑﻮاﺳﻄﺔ 27 و 06، 84، 63، 42، 81، 21, 6، 2، 1ذﻟﻚ ﻋﻨﺪ اﻟﺴﺎﻋﺔ 
أي ﻗﺮاءات  ﺷﺎذة ﺗﻢ ﺗﺄآﻴﺪهﺎ ﻣﻌﻤﻠﻴﺎ ﺑﺎﺳﺘﺨﺪام ﻃﺮﻳﻘﺔ  . )ehcoR( evitcA ®kcehC-uccAﺟﻬﺎز 
  . ﺋﻴﺔﺗﻢ ﺗﺠﻤﻴﻊ اﻟﺒﻴﺎﻧﺎت و ﺗﺤﻠﻴﻠﻴﻬﺎ ﺑﺎﺳﺘﺨﺪام ﺑﺮاﻣﺞ  اﻟﺤﺎﺳﺐ اﻵﻟﻲ اﻹﺣﺼﺎ. إﻧﺰﻳﻢ اﻟﻬﻜﺴﻮآﺎﻳﻨﻴﺰ
اآﺘﺸﻒ اﻧﺨﻔﺎض (.  ﻋﻴﻨﺔ ﻟﻜﻞ وﻟﻴﺪ9.8ﺑﻤﻌﺪل ) ﻋﻴﻨﺔ دم 437             ﺧﻼل اﻟﺪراﺳﺔ ﺗﻢ ﺗﺠﻤﻴﻊ  
ﻟﻮﺣﻆ إن ﻣﻌﻈﻢ . %6.61 ﻣﻦ هﺬﻩ اﻟﻌﻴﻨﺎت، ﺑﻴﻨﻤﺎ اآﺘﺸﻒ ﻓﺮط ﺳﻜﺮ اﻟﺪم ﻓﻲ 8.64%ﺳﻜﺮ اﻟﺪم ﻓﻲ  
ﻋﺎ وﺳﻂ ﺣﺎﻻت ﻓﺮط ﺳﻜﺮ اﻟﺪم آﺎﻧﺖ أآﺜﺮ ﺷﻴﻮ. هﺬﻩ اﻟﺤﺎﻻت ﻗﺪ ﺳﺠﻠﺖ ﺧﻼل اﻟﻴﻮم اﻷول ﻣﻦ اﻟﻌﻤﺮ
وﺟﺪ أن اﻧﺘﺸﺎر . 1:5.1ﺑﻤﻌﺪل4 0% ﻣﻦ اﻟﺤﺎﻻت ﺑﻴﻨﻤﺎ  ﻣﺜﻠﺖ اﻹﻧﺎث 06%اﻟﺬآﻮر ﺣﻴﺚ ﻣﺜﻠﻮا 
ﻋﻠﻴﻪ، ﻓﺎن . ﺣﺎﻻت اﻧﺨﻔﺎض  و ﻓﺮط ﺳﻜﺮ اﻟﺪم ﻳﺘﻨﺎﺳﺐ ﻋﻜﺴﻴﺎ ﻣﻊ اﻟﻌﻤﺮ اﻟﺤﻤﻠﻲ و اﻟﻮزن ﻋﻨﺪ اﻟﻮﻻدة
ﻤﺎ ﺳﺠﻞ ﻓﺮط  اﻟﺘﺪﻧﻲ ﻋﺎﻧﻮا ﻣﻦ  اﻧﺨﻔﺎض ﺳﻜﺮ اﻟﺪم، ﺑﻴﻨاﻟﺒﺎﻟﻎ ﻣﻦ اﻟﻤﻮاﻟﻴﺪ  ذوى وزن اﻟﻮﻻدة %7.58
اﻟﻤﻮاﻟﻴﺪ اﻟﺨﺪج  اﻟﺼﻐﺎر ﻟﻠﻌﻤﺮ اﻟﺤﻤﻠﻰ ﻣﺜﻠﻮا اﻟﻔﺌﺔ اﻷآﺜﺮ ﺗﻌﺮﺿﺎ  .  ﻣﻨﻬﻢ%1.75ﺳﻜﺮ اﻟﺪم ﻋﻨﺪ 
 %6.63ﺑﺎﻟﻤﻘﺎﺑﻞ ﺗﻢ رﺻﺪ ﻓﺮط ﺳﻜﺮ اﻟﺪم ﻓﻲ  .  ﻣﻨﻬﻢ%6.36ﻻﻧﺨﻔﺎض   ﺳﻜﺮ اﻟﺪم ﺣﻴﺚ رﺻﺪ ﻓﻲ  
ادت ﻧﺴﺒﺔ ﺣﺪوﺛﻪ وﺟﺪ أن ﻧﻘﺺ  ﺳﻜﺮ اﻟﺪم ﻗﺪ ز. هﺬﻩ اﻟﻨﺘﻴﺠﺔ آﺎﻧﺖ ذات دﻻﻟﺔ إﺣﺼﺎﺋﻴﺔ . ﻣﻦ هﺬﻩ اﻟﻔﺌﺔ
أﻇﻬﺮت اﻟﺪراﺳﺔ أن داء اﻟﺴﻜﺮ هﻮ اﻟﻮﺣﻴﺪ  .  %1.16وﺳﻂ اﻟﻤﻮاﻟﻴﺪ ﻵﺑﺎء ذوى ﻗﺮاﺑﺔ ﻋﺼﺐ، إذ ﺑﻠﻐﺖ
ﺿﻤﻦ  ﺗﻌﻘﻴﺪات اﻟﺤﻤﻞ اﻟﺬي ﻟﻪ ارﺗﺒﺎط  ﺳﺒﺒﻰ  ﺑﺎﺿﻄﺮاﺑﺎت ﺳﻜﺮ اﻟﺪم و ﺗﺤﺪﻳﺪا  ﺑﺤﺎﻻت ﻧﻘﺺ ﺳﻜﺮ 
ﺎﻟﻴﻞ اﻟﺴﻜﺮ اﻟﻮرﻳﺪﻳﺔ اﻷﻣﻬﺎت ﺑﻤﺤﻇﻬﺮ آﺬﻟﻚ أن اﺳﺘﻄﺒﺎب .  )100.0<P(اﻟﺪم ﻟﺪي  اﻟﻤﻮاﻟﻴﺪ  اﻟﺨﺪج 
  ﻟﺪى م، و ﻟﻜﻦ ﻟﻴﺲ  ﺑﺎﻧﺨﻔﺎض ﺳﻜﺮ اﻟﺪ ﻗﺒﻞ اﻟﻮﻻدة ذو ارﺗﺒﺎط ﺳﺒﺒﻲ ﺑﻔﺮط ﺳﻜﺮ اﻟﺪم
 ﻋﻦ ﻃﺮﻳﻖ اﻟﻌﻤﻠﻴﺎت  اﻟﻘﻴﺼﺮﻳﺔ اﻟﻄﺎرﺋﺔ   ﻟﻪ  ﺻﻠﺔ  ﺳﺒﺒﻴﺔ  اﻟﻮﻻدةأﺑﺎﻧﺖ اﻟﺪراﺳﺔ أﻳﻀﺎ  أن. ﻣﻮاﻟﻴﺪهﻦ 
  . ﺤﺎل ﻓﻲ ﻓﺮط ﺳﻜﺮ اﻟﺪمذات  دﻻﻟﺔ إﺣﺼﺎﺋﻴﺔ  ﺑﺎﻧﺨﻔﺎض ﺳﻜﺮ اﻟﺪم ﻟﺪى اﻟﻤﻮاﻟﻴﺪ اﻟﺨﺪج، و آﺬﻟﻚ اﻟ
              ﻣﻦ ﺧﻼل هﺬﻩ اﻟﺪراﺳﺔ ، ﺗﻤﺜﻠﺖ اﻟﻌﻮاﻣﻞ اﻟﻤﺮﺗﺒﻄﺔ ﺑﺎﻧﺨﻔﺎض ﺳﻜﺮ اﻟﺪم ﻟﺪي  اﻟﻤﻮاﻟﻴﺪ 
 اﻟﺨﺪج 
اﻧﺨﻔﺎض اﻟﺤﺮارة  ، زرق اﻟﺴﻜﺮ  ،ﻋﻨﺪ اﻟﻮﻻدة، ﻣﺘﻼزﻣﺔ ﺿﺎﺋﻘﺔ اﻟﺘﻨﻔﺲﻣﻌﺪل أﺑﻘﺮ اﻧﺨﻔﺎض : ﻓﻲ اﻵﺗﻲ
ﺑﺎﻟﻤﻘﺎﺑﻞ، ﻓﺎن اﻟﻌﻮاﻣﻞ ذات اﻻرﺗﺒﺎط ﺑﺤﺎﻻت . ﺔﺔ اﻟﻔﻤﻮﻳورﻳﺪﻳﺎ ﺑﻄﺮﻳﻘﺔ ﻣﺘﻘﻄﻌﺔ ﺑﺎﻹﺿﺎﻓﺔ  ﻟﺘﺄﺧﻴﺮ اﻟﺘﻐﺬﻳ
زرق اﻟﺴﻜﺮ ،  إﻋﻄﺎء ﻋﻘﺎر اﻷﻣﻴﻨﻮﻓﻴﻠﻴﻦدة، ﻋﻨﺪ اﻟﻮﻻﻣﻌﺪل أﺑﻘﺮاﻧﺨﻔﺎض : ﻓﺮط ﺳﻜﺮ اﻟﺪم ﺷﻤﻠﺖ
اﻻﻧﺘﺎﻧﺎت اﻟﺪﻣﻮﻳﺔ اﻟﻤﺒﻜﺮة و  اﻟﺘﺨﺜﺮ اﻟﺪﻣﻮي داﺧﻞ ،ورﻳﺪﻳﺎ ﺑﻄﺮﻳﻘﺔ ﻣﺘﻘﻄﻌﺔ، اﻟﻨﺰف داﺧﻞ اﻟﺒﻄﻴﻦ 
  .اﻷوﻋﻴﺔ اﻟﻤﻨﺘﺸﺮ
 ﺣﺎﻟﺔ ﻻﻧﺨﻔﺎض ﺳﻜﺮ اﻟﺪم ، ﺗﻘﺎﺑﻠﻬﺎ %3.46ﻤﻦ ﻓﺌﺔ اﻟﻤﻮاﻟﻴﺪ اﻟﻠﺬﻳﻦ ﺗﻮﻓﻮا، ﺗﻢ رﺻﺪ             ﺿ
ﻋﻠﻴﻪ ﻳﻤﻜﻦ إﺟﻤﺎل اﻟﻘﻮل ﺑﺎن اﺿﻄﺮا ﺑﺎت ﺳﻜﺮ اﻟﺪم .  ﺣﺎﻻت ﻓﺮط ﺳﻜﺮ اﻟﺪم %9.24ﺑﻤﺴﺘﻮى أﻗﻞ
 . اﻟﻤﺒﻜﺮة ﻋﻨﺪ اﻟﻤﻮاﻟﻴﺪ اﻟﺨﺪج ذات دﻻﻻت ﺗﻜﻬﻨﻴﺔ ﺳﻴﺌﺔ ﻋﻠﻰ ﻓﺮص اﻟﻌﻴﺶ اﻵﻧﻴﺔ ﻟﻬﺆﻻء اﻟﻤﻮاﻟﻴﺪ
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 1. INTRODUCTION  AND  




    The following World Health Organization (WHO) definitions will be 
    used:  
1.1.1.  Preterm Infant : 
          Any infant  Born before 37 completed weeks of gestation. 
              1.1.2.  Early Neonatal Glycemic status:                                                              
Blood  glucose level during the first 72 hours of life (1).  
1.2. INCIDENCE OF PREMATURITY. 
       Preterm birth refers to a birth that occurs before 37 completed 
weeks( less than 259 days) of gestation (1). Premature infants are 
classified by their birth weights. Those who weigh between 1500 and 
2500g are defined as low birth weights(LBW). Between 1000 and 
1500g are very low birth weights(VLBW), while those below 1000g are 
termed extremely low birth weights (2). 
       In the United States, an average of (07.5%) of liveborn neonates 
are premature (2). In Sudan, however,  no data is available at the level  
of the Federal Ministry of Health; instead statistical records are 
available at the obstetrical departments in most hospitals. For 
example, in Soba University Hospital, Khartoum, Sudan  which is a 
tertiary hospital with a feto-maternal unit, the annual percentage of 
preterm births is around (09.8%) from the total births (3).  
         In Omdurman Maternity Hospital, Khartoum, Sudan, where this 
study was done, the percentage is (07.3%). Preterm infants comprise 
about one third of the nursery  admissions every year. The average 
survival rates of these infants is around (46.4%); an exceedingly low 
figure (4). This is probably due lack of ventilatory support facilities that 
most of these babies will need at one point or another. It is worth 
mentioning that Omdurman Maternity Hospital serves the whole 4 
million population of Greater Omdurman Province with an average of 
14 to 15 thousands deliveries per year. The number of admissions to 
the nursery is estimated to range between 1300 to 1500 neonates 
each year. The estimated average early neonatal death is 22 in 1000 
live births(4). 
1.3. HISTORICAL BACKGROUND. 
         It is almost a century since hypoglycemia  was first described in 
children and over fifty years since it was  recognized in  newborns  and  
 
older infants (5). The vulnerability of premature infants and those of 
diabetic mothers to hypoglycemia was recognized early in the history 
of neonatal medicine as mentioned by Miller & Ross in 1940; Norval in 
1950; McQuarrie in 1954 and by  Farquhar in 1954 (6,7). The transient 
nature of hypoglycemia and the apparent infrequency of clinical 
manifestations led many to consider this as  "physiological", in contrast 
to hypoglycemia caused by metabolic and endocrine diseases (8).  
      However, in 1959 Cornblath et al described eight, 2-day old infants 
born to mothers with pre-eclamptic toxaemia in whom symptoms 
(apnoea, cyanosis, coma and convulsions) were associated with 
reduced blood glucose concentrations (1-24 mg /dl). They described a 
clinical response to the infusion of intravenous glucose and drew 
attention to the "self-limited but quite refractory" course of 
hypoglycemia. The outcome of this small group of infants was poor. 
Five were normal when followed-up at two weeks to eleven months but 
one died and two had persisting neurological abnormalities (9). Further 
descriptions of neurological sequelae associated with symptomatic 
hypoglycemia (i.e.that associated with clinical signs which resolve at 
increased blood glucose concentration) in the newborn followed (10,11).  
 
The  introduction in the early 1970's  of reagent  strip  glucose  assays    
(e.g. DextrostixTM) for cotside screening of newborns at risk, led to 
clinical classifications of neonatal hypoglycaemia by some 
investigators  like Fluge in 1974 and  Gutberlet  and  Cornblath  in 
1975 (12).  
          In the 1940's and 1950's preterm infants were starved for the 
first 24 hours of life in order to reduce the incidence of aspiration (13). 
Smallpeice and Davies showed that nasogastric tube feeding of small 
infants (birth weight 1-2 kg) using graded volumes of milk was safe and 
reduced the frequency of hypoglycemia, jaundice and dehydration 
when compared with historical controls (14). 
1.4. Glucose Homeostasis and Metabolic Adaptation at    Birth. 
       1.4.1. The fetal nutritional and metabolic environment. 
                Glucose, amino acids and lactate are the principal energy 
substrates during fetal life, glucose alone provides about half the total 
energy requirement (15). Glucose crosses the placenta by facilitated 
diffusion along a concentration gradient between maternal and fetal 
plasma,   fetal  plasma glucose   concentrations   being    (70-80%)   of  
those in maternal venous plasma (16).  
         
         The fetal endocrine milieu is dominated by insulin. Insulin does 
not cross the placenta, fetal secretion being influenced by 
concentrations of both glucose and amino acids in fetal plasma. The 
fetal insulin axis is therefore independent of the mother's (16). The β-
cells of the fetal pancreas become responsive to glucose relatively late 
in gestation and β-cell mass increases markedly in the last trimester of 
pregnancy (17). It has been speculated that this may be a critical 
developmental period at which substrate provision programmes 
pancreatic islet development irreversibly influencing the metabolic 
response to glucose in later life and predisposing to certain patterns of 
adult disease (18). Insulin promotes anabolism in the fetus by 
stimulating uptake of glucose into muscle and adipose tissue . Thus 
the last trimester of pregnancy is a period of rapid fetal growth, 
particularly deposition of fat in adipose tissue. In this way, energy 
stores are laid down in preparation for birth (17). 
     1.4.2. The regulation of blood glucose concentration after birth. 
             Normally blood glucose concentration is regulated within a 
much narrower  range than    other  metabolic  fuels,  varying  only  two   
to  three-fold (15). The liver is the principal site of endogenous glucose 
production, though after prolonged fasting up to 10% of circulating  
glucose may originate in the kidney (19). Glucose is produced by 
glycogen breakdown (glycogenolysis) or is synthesized from glycerol, 
lactate, pyruvate and glucogenic amino acid precursors, of which 
alanine is quantitatively most important (15).  
        The general term used to describe the processes by which the 
body makes glucose available in the fasted state is counterregulation 
(20). Insulin is secreted in response to a rise in blood glucose 
concentrations. The principal counterregulatory hormones are 
glucagon and adrenaline. Hepatocyte cAMP levels fall in the presence 
of insulin, thereby stimulating glycogen synthesis. Both  glucagons and 
adrenaline increase hepatocyte cAMP levels and favour glycogen 
breakdown (19,20). Infusion of glucose into adults suppresses 
endogenous glucose production both through a direct effect of glucose 
concentration and through enhancement of insulin secretion .The 
same phenomenon has been observed in normal newborn infants 
though the degree of suppression is very variable and less marked in 
sick, stressed infants, particularly those who are very preterm (21,22).  
This probably demonstrates variable expression of the 
counterregulatory  response in  hypoglycemic  and   stressed 
newborns (19,22). 
    
 
 
 1.4.3. Metabolic events at birth. 
             At birth, the transplacental supply of nutrients, especially 
glucose, to the newborn is interrupted abruptly. This sets into motion a 
complex cascade of metabolic and endocrine events that allow a 
healthy term newborn to adjust to his or her new environment. This 
cascade is triggered by a surge in the concentrations of glucagon and 
catecholamines and cessation of insulin secretion (19,23). Glucagon and 
catecholamines increase glycogenolysis, gluconeogenesis, lipolysis, 
and ketogenesis (23). The complex enzyme machinery responsible for 
these processes is mature in term healthy newborns. In contrast, the 
metabolic and endocrine processes allowing the transition to the 
extrauterine environment are not developed fully in preterm infants and 
those who have suffered intrauterine growth restriction (IUGR), placing 
these newborns at significant risk of hypoglycemia (24). 
        A key enzyme that controls the terminal steps in these processes 
is hepatic  microsomal  glucose-6-phosphatase,  which  catalyzes  the  
dephosphorylation of glucose-6-phosphate to glucose and regulates 
the final step in hepatic glucose production (25). Hepatic glucose-6-
phosphatase activity is low before birth in preterm infants and can 
remain low in some preterm infants for several months after birth (24,25) . 
This delayed postnatal appearance of hepatic glucose-6-phosphatase 
in preterm infants may make them vulnerable to repeated 
hypoglycemic episodes and resultant cerebral damage or to the risk of 
sudden and unexpected death. The low activity of hepatic glucose-6-
phosphatase activity in preterm infants also may account for the 
diminished responses to intravenous and intramuscular glucagons (26). 
It has been shown that about 18% of preterm infants have problems in 
maintaining normoglycemia at the time of discharge if a feeding is 
omitted or delayed (27).                                                                                                 
         Hawdon et al studied 62 clinically stable preterm babies (median 
gestation 31 weeks, range 25-36 weeks; median birth weight 1760 g, 
range 830-3203g). Non-esterified fatty acid and ketone body 
concentrations of preterm infants were significantly lower than those of 
term infants. Moreover, preterm infants with low blood glucose levels 
did not show increased ketone body concentrations as did infants born 
at term (28). 
    1.4.4. Effect of early feeding on blood glucose concentration.    
              Most infants <28 weeks of gestation show immature patterns 
of bowel motility though early feeding has been shown to hasten 
adaptation to   the  pattern    seen in    more      mature     babies (29).  
 
A randomized controlled study of babies who weighed less than 1850g 
at birth found that human milk feeds more  rapidly tolerated  than 
formula feeds (30). 
          Beard et al alternately allocated term and preterm infants to an 
"early feeding" group (fed with formula from 6 hours of age) and a 
group fasted for 72 hours. Mean blood glucose concentration at 72 
hours was 40 mg dl-1 (2.2 mmol l-1) in the fasted term infants, as 
compared to 68 mg dl-1 (3.8 mmol l-1) in the "early-fed" group. Fifty 
eight percent of the fasted premature infants had a blood glucose 
concentration of <25 mg dl-1 (1.4 mmol l-1) by 72 hours of age, as 
compared to only 4% (1 infant) among the early-fed group; though no 
complications were noted. The fasted group also showed a reduced 
increment in blood glucose concentration on injection of glucagon and 
adrenaline,  suggesting a  relative  reduction in their   glycogen    
stores.  Free fatty acid  concentrations nevertheless rose in  the  fasted  
infants and over 50% of the fasted healthy premature infants showed 
ketonuria by 48-72 hours of age (31).  In a Cambridge study by Whitby 
et al ,of 269  infants weighing 1.8-2.5 kg  who were provided with 60 ml 
kg-1 d-1 of milk on the first day (increasing by aliquots of 30 ml kg-1 d-1) 
only 5 developed hypoglycemia. All were asymptomatic (32). 
 
1.5. HYPOGLYCEMIA AMONG PRETERM INFANTS. 
       1.5.1. The dilemma of definitions.  
                A lot of controversy about the definition of neonatal 
hypoglycemia exists (33). Confusion about the definition of "neonatal 
hypoglycemia" was well documented by Koh et al who surveyed 
paediatric textbooks and the opinion of consultant paediatricians in the 
United Kingdom (33). Changing care practices account for the wide 
variety of threshold plasma and blood glucose concentrations used in 
the past to define "hypoglycemia" statistically. Approaches to defining 
abnormally low blood glucose  concentration  have                 included: 
statistical,   metabolic, neurophysiological   and neurodevelopmental  
approaches (34).  
          Although the previous studies that were performed when 
premature infants   were fasted in the 1st day of life suggested that 
preterm infants may be unaffected by low blood glucose values, 
evidence does not support these conclusions (34). Both premature and 
full-term infants are at risk for serious neurodevelopmental deficits from 
equally low glucose levels (35). This risk is related to the depth and 
duration of the hypoglycemia. Furthermore counterregulatory 
responses differ  significantly  between  term  and preterm  infants ,  
suggesting that the threshold for a "safe" blood glucose concentration 
in the preterm infant is higher than that for a term infant and not lower 
as implied by earlier data as was cited by Cornblath & Reisner earlier 
in  1965 (11,35).  
           Several authorities have recommended treatment when blood 
glucose concentration is less than 2.6 mmol l-1(34). This figure has three 
principal justifications: first that the counterregulatory response of 
preterm infants is blunted, secondly that there is evidence of 
neurophysiological dysfunction at this level and, third, that there is 
evidence of subsequent neurodevelopmental delay in preterm infants 
exposed to hypoglycemia of this severity. Each of these justifications 
can, however, be challenged (36). 
     1.5.2. Prevalence of hypoglycemia among preterm infant. 
                Estimates of the prevalence of hypoglycemia clearly vary 
with the definition chosen, the population studied (postnatal age, 
gestation, weight for gestational age), and the pattern of care (37).  
Hawdon et al, reviewing the literature, quote incidences of 
hypoglycemia in term infants ranging between (0 and 08%) and 
between (3 and 15%) in preterm infants (38).  Kinnala et al, from Finland 
studied the prevalence  of  hypoglycemia  in  40  preterm  babies  who  
 
were receiving breast milk and intravenous10% glucose during the first 
five days of life. Moderate hypoglycemia was common (42%), severe 
hypoglycemia  was  documented in  four of  these infants during the  
first day (39). Information on the incidence of neonatal hypoglycemia in 
developing countries is very limited (34). Anderson et al, observed that 
(38%) of uncomplicated term infants born in Katmandu, Nepal showed 
a blood glucose concentration of <2.6 mmol l-1 during the first 50 hours 
of life . Low birth weight and hypothermia were associated with 
hypoglycemia which was present in (55%) of those weighing <2500 g, 
and (32 %) of those >2500 g. Similarly, 57% of those with a rectal 
temperature  of  <35.5OC at the  time of  sampling  were  hypoglycemic  
compared to (32%) of those who were not (40). 
            Gutberlet & Cornblath estimated the prevalence of 
hypoglycemia (defined as serum glucose concentration <30 mg 100 
ml-1) as 4.4 per 1000 total live born births, 15.5 per 1000 low birth 
weight infants (41). In comparison, Lubchenco & Bard arrived at much 
higher estimates: (11.4%) of all nursery admissions and (20.3%) of 
those premature or low birth weight had blood sugar <30 mg 100 ml-1 if 
screened before feeding at 6 hours of age (37).   Zanardo et al, 
assessed the hypoglycemia incidence and the relative risk factors for  
the affected preterms  in Padova in Italy. They found hypoglycemia in 
(35%) of the studied population. Associated with that were five major 
factors: caesarean section, intrauterine malnutrition (SGA), NICU 
admission, gestational age between 30-33 and twinning. At levels of 
dextrostix less than 20mg/dL (i.e. severe hypoglycemia) three more 
factors were found: cardiopulmonary resuscitation at birth, respiratory 
distress syndrome and gestational age between 26-29 weeks (26).                   
Haronn Chisshti  from Pakistan screened 221 neonates for 
hypoglycemia.  Ninety one showed one or more blood glucose level 
less than 40 mg/dL. Of these, 51 cases (56 %) were low birth weight.  
Seventy one percent  had birth weights less than 2000g. Moreover, 
hypoglycemia was   more  frequent in those less than 30 weeks of 
gestation (42). 
      1.5.3. Effects of hypoglycemia 
                The cerebral cortex, hippocampus, and caudate nucleus are 
the regions principally affected by experimentally-induced 
hypoglycemia sufficient to create an isoelectric EEG (43). This differs 
from the distribution of hypoxic/ischaemic damage; the dentate gyrus is 
particularly rarely affected by ischaemia but characteristically damaged 
in hypoglycemia. Brain stem and posterior fossa structures are least  
affected by hypoglycemia(44). Kraus et al studied the cerebral 
arteriovenous difference (∆AV) in ketone body concentration among 11 
preterm and 2 term newborns fasted for 6 hours. ∆AV and ketone body 
concentration were positively correlated with cerebral uptake of ketone 
bodies, accounting for around (10%) of overall brain energy balance. In 
this study there was net cerebral production of lactate and pyruvate, 
suggesting that ketone bodies are more important than lactate as an 
alternative cerebral fuel to glucose (45). 
          Pryds et al identified increased plasma adrenaline 
concentrations and cerebral blood flow (measured using 133Xe) in 
preterm infants whose blood glucose fell below 1.7 mmol l-1(46). In 
another study Scov and Pryds from Denmark investigated changes in 
cerebral  blood volume by means of    near-infrared spectroscopy in 18 
preterm newborns during treatment with intravenous bolus glucose. 
Their observation was that individual reductions in cerebral blood 
volume were inversely related to the pretreatment concentration of 
glucose, whereas there was no relation between changes in cerebral 
blood volume and alterations in blood gas values or in mean arterial 
blood pressure. It is suggested that previously unperfused capillaries 
are recruited to maintain the glucose  transport   into   the     neurons of  
hypoglycemic preterm newborns. The rapidity whereby vessels adjust 
to alterations in glucose levels indicates the existence of a cerebral 
glucose sensor (47). 
            Hypoglycemia in the neonatal period can have long-term 
neurological sequelae. These were identified in up to (35%) of those 
with symptomatic neonatal hypoglycaemia and (20%) of those with 
asymptomatic hypoglycaemia (48). Preterm infants and  infants  that are  
small for gestational age (SGA) seem to be at greater risk of sequelae  
because of metabolic immaturity (49). 
     1.5.4. Aetiolgy of hypoglycemia in preterm babies. 
              Reasons for the preterm infant's propensity to hypoglycaemia 
are many. First, energy reserves at birth, both as liver glycogen and 
fat, are greatly reduced. Differences in fat content are particularly 
important; fat accounts for only (02%) of body weight at 28 weeks of 
gestation but about 16% at term. Although fat is not itself convertible to 
glucose, mobilization and oxidation of fat reduces glucose uptake and 
oxidation (23).    
         Second, recent evidence indicates that preterm infants show 
plasma insulin concentrations greater than those of term infants when 
related          to   plasma    glucose  concentration (50).   It  appears  that  
the   elevated  insulin : glucose ratio and relative immaturity of 
ketogenesis persist for some months after birth (17). This phenomenon 
is unexplained though it is possible that the greater protein intake of 
preterm infants, necessary to match their faster growth potential, is an 
insulinogenic stimulus. It has been known for some years that insulin 
secretion  in   term  infants   (as  reflected by   C-peptide   excretion)  is  
modified by dietary protein intake and related to plasma valine: glycine 
ratio (50).Third, it is likely that gluconeogenic pathways are less mature 
than in term infants. For example, expression of microsomal glucose-6-
phosphatase was reduced in liver necropsy samples obtained from 
preterm infants up to 1 year of age and ranging between 24-36 weeks 
of gestation at birth. This enzyme catalyses the final step of both 
glycogenolysis and gluconeogenesis (25).  
             Neonatal sepsis is a well known single cause of many 
metabolic derangements. In accordance with this, Fitzgerald et al 
studied the  early  effects of sepsis on carbohydrate metabolism in 29 
preterm infants in the first 48 hours of life. Six out of these had 
confirmed sepsis. Infants with sepsis had significant elevations of 
plasma lactate concentration (P< 0.003) but normal pH. The dextrose 
infusion  rate  was  also  significantly  elevated  in  the  infected  infants  
(P< 0.01). No hypoglycemia or hyperglycemia was observed in either 
group. No significant difference in plasma insulin concentration was 
observed. Their conclusion was that significant elevations in plasma 
lactate concentrations and dextrose infusion rate may be early clinical 
markers of neonatal sepsis in the first 48 hours of life (51).      
           It has been suggested by many authors that there is an 
association between hypoglycemia and hyperammonemia in preterm 
infants. Sann and Dellamonica, for example, measured the plasma 
glucose, blood urea and ammonia simultaneously in 44 preterm  
infants a few hours after birth. When the concentration of plasma 
glucose was below 30 mg/dl, plasma ammonia concentration was 
significantly higher than in normoglycemic infants (P<0.01). These data 
showed that hyperammonemia can be associated to hypoglycemia in 
low birth weight infants. Therefore, further investigations are required 
to determine the link between urea and glucose production rates in  
hypoglycemic  newborns  and whether hyperammonemia  participates  
in the  deleterious  effects of hypoglycemia on the neonatal brain (52).          
            Hyperinsulinism in infancy  is a rare cause of recurrent and 
severe hypoglycemia in the newborn infant and during the first 
postnatal weeks. It usually appears in infants born at term. However, 
Hussain and Green recently reported seven infants born at 31–36 
weeks gestation who experienced severe persistent hyperinsulinism. 
All   infants   showed  a   considerably    increased  glucose    infusion 
requirement, ranging from 14 to 22 mg/kg/min. All babies had 
biochemical profiles reflecting hyperinsulinaemic, hypoketotic, 
hypofattyacidaemic hypoglycemia with increased glucose 
requirements. The plasma ammonia concentration was normal in all of 
the babies. Plasma cortisol levels were measured in five of the babies 
and were found to be inappropriately low at the time of hypoglycemia.  
Their conclusion was that hyperinsulinism should be considered in the 
differential diagnosis of severe hypoglycemia in preterm infants (53). 
      1.5.5. Treatment and Prevention   
                 Moderate, asymptomatic hypoglycemia should first be 
treated by adjusting the enteral feeding regimen.If this approach fails, 
intravenous therapy should be instituted when facilities are available. 
Whether glucose or milk is given, a blood glucose measurement 
should be repeated preferably within the hour (54). Studies in 
hypoglycemic infants and in preterm and SGA infants have shown that 
feeding lipid produces an increase in blood glucose, and non-esterified 
fatty acid concentrations (55).   Intravenous treatment  should  be   used  
under any of the following circumstances  :-  
     i.  Enteral treatment has failed . 
    ii.  Hypoglycemia is severe (<1.1 mmol l-1).  
    iii. The baby is unwell or has signs which may be attributable to   
hypoglycemia (56) . 
            The practice of a priming glucose "bolus" (2.5-3.0 ml of 10% 
dextrose kg-1 min-1 administered at a rate of 1 ml min-1) before glucose 
infusion, is controversial (34). Some authorities (34) recommend it but 
others have argued that the rate of glucose entry in such 
circumstances exceeds uptake, provoking "rebound hypoglycemia" 
through enhancement of insulin secretion and inhibition of glucagon 
secretion (34,57,58). Excessively rapid administration of glucose moreover 
has potential to cause hyperosmolar cerebral  oedema, as described in 
older children (57).  Any bolus given must be  followed  by a  continuous  
infusion of   glucose,  initially   providing  4-8  mg      kg-1 min-1. There is 
no place for treatment with intermittent  glucose boluses alone (56). 
         Charsha et al, from USA studied the efficacy and safety of 
intravenous glucagon infusion in a large cohort of persistently 
hypoglycemic sick preterm infants. It was shown that continuous  
 
intravenous infusion of glucagon for treatment of hypoglycemia in sick, 
preterm infants is effective. Further, glucagon infusions were not 
associated with thrombocytopenia. Severe hyponatremia (<120 mEq/L) 
occurred infrequently and was easily corrected. They suggested that 
Glucagon is an effective  glycogenolytic agent (59). However, preterm 
infants have very poor glycogen stores and it is thought that glucagon 
also stimulates gluconeogenesis by inducing phosphoenolpyruvate 
carboxykinase, the major enzyme of gluconeogenesis, which then 
results in increased endogenous glucose production (60). 
          The most effective method of preventing hypoglycemia is 
feeding with milk as soon as possible after delivery(29). Breastmilk is 
preferred to formula because it appears to promote ketogenesis (28). 
Concern about the relationship between high early feed volume and 
necrotising enterocolitis may be unjustified, being based on case-
control data (28) and retrospectively controlled studies (30). Preterm 
infants with features of respiratory distress should not be enterally fed 
but should be treated with intravenous glucose until respiratory rate 
begins to fall (34). Sustained coordination of suckling and swallowing is 
present from about 32 weeks of gestation and many such infants may 
be allowed an opportunity to suckle (61,62). 
 
1.6. HYPERGLYCEMIA IN PRERM INFANTS. 
          1.6.1. Aetiology 
                    Hyperglycemia in preterm infants is defined as a blood 
glucose level of more than or equal to 125 mg/dl which is equivalent to 
7mmol/l (1). Many extremely preterm infants develop hyperglycemia in 
the first week of life during continuous glucose infusion (62). Many 
conditions are associated with hyperglycemia in preterm neonates 
because they are very susceptible to changes in carbohydrate 
homeostasis (36). In general, the risk of hyperglycemia is greatest in 
neonates who are immature and have some degree of perinatal 
asphyxia and respiratory distress (64).  
           The most common exogenous factor is parenteral glucose 
administration (65). It should also be remembered that during the 
neonatal period, pain causes increases in the liberation of epinephrine, 
norepinephrine, cortisol, and glucagon and a decrease in insulin. 
These pain-induced hormonal changes could result in exacerbating 
hyperglycemia in preterm neonates (66). Hyperglycemia readily 
develops during intravenous glucose administration in premature 
infants (63).  
         
           Ekblad et al conducted a randomized controlled study 
comparing the incidence of hyperglycemia in relation to the 
concentration of dextrose infusion (5 and 10 % respectively) given to 
preterm infants. Glucose homeostasis was efficiently maintained in 
both groups and there seemed to be no statistically significant 
difference for the incidence of both hypo and hyperglycemia (67). 
Hyperglycemia can also be triggered by intravenous lipid infusion or by 
surgical intervention (65). In addition to prematurity, other contributing 
factors include inappropriate hormone levels and conditions conducive 
to hormonal imbalance (66). Thus, intrauterine stress, treatment with 
aminophylline  or corticoids, and hypoxemia are associated with 
elevated incidence of hyperglycemia (68, 69, 66) .  
            Stress had long been attributed to the causation of 
hyperglycemia (65). Zobel et al from Germany looked at the prevalence 
of hyperglycemia in 11 stressed preterm infants on total parenteral 
nutrition (TPN) . The main predictors to “stress” were respiratory 
distress syndrome (RDS) and intraventricular haemorrhage (IVH). 
Plasma insulin values increased in the whole study population  during 
the first five days after birth while blood glucose and plasma insulin  
 
 
values were significantly higher in those who had severer RDS and 
IVH.  Given this, the  conclusion was that impaired glucose utilization 
in severely stressed preterm infants with parenteral nutrition might be 
due to stress induced peripheral insulin resistance (70). However, Lilien 
et al compared levels of insulin, glycerol and cortisol in stressed 
hyperglycemic preterm infants to those in stressed euglycemic preterm 
infants. They clearly found that  the etiology of hyperglycemia in 
stressed preterm infants cannot be attributed to hypoinsulinemia or to 
hypercortisolemia, and is not associated with increased glycerol levels. 
There was no difference in mortality between stressed hyperglycemic 
and stressed euglycemic infants; stress, rather than hyperglycemia, 
was related to mortality (66). 
            More recently, Mitanchez-Mokhtari  evaluated the serum levels 
of proinsulin, insulin, and C-peptide secreted during transient 
hyperglycemia in the less than 30 weeks preterm infants by specific 
immunoassays. In addition, the changes in ß-cell peptide levels were 
analyzed during and after intravenous insulin infusion. Insulin and C-
peptide levels did not differ in hyperglycemic subjects and in preterm 
controls.  Proinsulin   concentration  was  significantly  higher   in   the  
hyperglycemic group. Compared with term neonates,   proinsulin    and  
 
C-peptide levels were higher in normoglycemic preterm infants. During 
and after insulin infusion in hyperglycemic neonates, plasma glucose 
concentration fell and proinsulin and C-peptide levels were also 
lowered. These data suggested that preterm neonates are sensitive to 
changes in plasma glucose concentration, but proinsulin processing to 
insulin is partially defective in hyperglycemic preterm neonates. 
Moreover, hyperglycemic neonates are relatively resistant to insulin 
because higher insulin levels are needed to achieve euglycemia in this 
group compared with normoglycemic neonates. It was also shown that  
insulin infusion is beneficial in extremely preterm infants with transient 
hyperglycemia (71). 
        1.6.2. Prevalence 
                   Little is known about the exact magnitude of the problem 
possibly because of the controversy bout the definition (56). Louik et al 
studied the prevalence of hyperglycemia in preterm infants admitted in 
the NICU receiving infusions of dextrose 10%. Hyperglycemia related 
to 10% dextrose solution was observed in (05.5%) of the studied 
population, a rate similar to that observed for hypoglycemia which was  
(06.7%) among the study population (63). There was a highly significant 
trend toward an increasing risk of hyperglycemia with decreasing body  
weight, such that the risk of hyperglycemia among infants weighing 
less than 1,000 g was 18 times greater than the risk among infants 
weighing more than 2,000 g (72). 
               Falcão et al in São Paulo, Brazil studied the glycemic status 
of 41 preterm infants admitted to the nursery . Hyperglycemia was 
detected in (11.5%) of the samples taken. The principal predictive 
variables for hyperglycemia in this study, in decreasing order of 
importance, were an unstable clinical status, the glucose infusion rate 
>6 mg/kg/min, and the gestational age 31 wk (64) 
         1.6.3.  Effects of hyperglycemia 
                  Hyperglycemia almost always  occurs in the  first hours  to 
days  of  life (36). Hyperglycemia is associated with polyuria which is 
due to glycosuria (rare if blood glucose < 250 mg/dL); intracranial 
hemorrhage if hyperglycemia occurs rapidly as a result of an abrupt 
increase in plasma glucose concentration, e.g., following an 
intravenous  D25W or D50W glucose bolus (56). The clinical 
significance of hyperglycemia during the neonatal period differs from  
center to center and from study to study (72). However, many authors 
had suggested that increases in blood glucose levels may affect renal 
function or possibly lead to intraventricular hemorrhage in infants at 
risk (64,65). 
          1.6.4. Management 
             The two major steps in managing infants with hyperglycemia  
are the reduction in the glucose infusion rate and the administration of 
intravenous insulin (65). The upper limit at which a decrease in glucose 
infusion rate or the installation of insulin therapy is indicated is a blood 
glucose level between 125 and 240 mg/dl (73). In practice, however, 
intervention in hyperglycemia depends on individual clinical 
circumstances and on the risk of complications, which occur most 
commonly in newborn preterm infants submitted to glucose infusion or 
parenteral nutrition (70). 
               The question of assuring an adequate supply of glucose to 
the tissues of preterm neonates without provoking hyperglycemia and 
consequent complications constitutes a real concern, especially when 
there are factors which prevent oral feeding (71). One approach is giving 
insulin infusion after priming  the tubing with a  higher  concentration  of  
insulin reaching up to 5 U/mL(74) . Avent and Whitfield in Dallas, USA 
(74) assessed this approach in comparison to the addition of serum 
albumin to the insulin infusion solutions; a method employed by some 
to combat the problem of technical errors and to minimize the insulin 
loss (74). They concluded   that  not  adding     albumin to    the    insulin  
admixture resulted in a considerable cost savings and avoids the 
exposure of the patients to human sera. It also appeared that adequate 
control of hyperglycemia is achieved by flushing the intravenous tubing 
with 10 mL of insulin admixture and allowing the insulin syringe and 
tubing to sit for 30 minutes  (74).  It is worth remembering that glucose 
levels in neonates receiving 10% dextrose solution be carefully 
monitored, and the total dextrose dose be adjusted accordingly.  
 
1.7. SCREENING. 
         The WHO has recommended for the prevention and treatment of 
neonatal hypoglycemia that for newborns at risk including preterm 
infants, the blood glucose concentration should be measured at around 
4-6 hours after birth and before a feed, if reliable laboratory 
measurements are available (34) 
            Hamid MH et al in Lahore Pakistan, conducted a study to 
determine the accuracy and the reliability of a glucometer in 
comparison to the conventional  hexokinase method in detecting 
neonatal hypoglycemia and 292 paired samples were tested. They 
concluded that the Accutrend alpha®  glucometer(Roche) they used 
was useful in screening and detecting low levels of neonatal blood 
glucose, however all low levels should be promptly confirmed by 
chemical laboratory (75).  
 
1.8. RELEVANT STUDIES IN SUDAN. 
          Few studies had addressed the issue of hypoglycemia among 
Sudanese neonates, while none looked into the problem of neonatal 
hyperglycemia. In 1986, Thuraya. M. Zein conducted a study on 
neonatal hypoglycemia in Khartoum and Omdurman areas. She 
estimated the incidence of hypoglycemia to be  (34.7%) of all neonates 
within the first 48 hours. This incidence, she found, declined over the 
time. The mortality rate among the hypoglycemics was 15.3%. The 
incidence of hypoglycemia during the first 6 hours of life  among the 
preterm  infants  was  (38.7%) .  Hypoglycemia  was 1.2  folds  among  
preterm infants who were AGA, and was 2.5 folds among term SGA 
neonates than it was among the non-exposed group term AGA 
neonates.  According to that study, male babies experienced more 
hypoglycemic events than females (76).    
          Nafisa Mohamed studied the effects of maternal diabetes 
mellitus on the infants A lower mean gestational age than the controls 
was observed probably   due to the effects  of   diabetes   or  obstetric  
management. The level of blood glucose at two hours of age dropped 
to less than 50% of the cord glucose. An endocrine factor is thought to 
be responsible for this phenomenon. Hypoglycemic episodes were 
documented in (05.5%) of   the studied group. Respiratory problems 
were the leading cause of mortality (77).  In another recent work, Sarah 
A.Salih studied the early neonatal outcome of preterm infants delivered 
in Soba University Hospital, Khartoum. Respiratory distress syndrome 
was the major cause of morbidity and mortality among the studied 
population. The mortality rate for the whole group was (26%) by the 









   
 
1.9. JUSTIFICATIONS 
        1.9.1. Preterm infants are mostly vulnerable to changes in blood       
glucose levels rendering them at increased risk for hypo and 
hyperglycemia- associated  morbidity and mortality. 
    1.9.2. Glycemic monitoring of preterm infants is of paramount   
importance in the management of  preterm infants admitted to 
nurseries. 
        1.9.3. Few studies were done on Sudanese preterm infants 








 1.10. OBJECTIVES 
        1.10.1.To study the prevalence of early hypo and    hyperglycemic 
episodes in preterm infants admitted to the special care 
baby unit (SCBU)  in Omdurman Maternity Hospital. 
        1.10.2.To describe the possible clinically associated risk factors for 
the development of both hypo and hyperglycemia in these 
preterm infants. 
         1.10.3.To define the association between the short term outcome 











2. PATIENTS AND METHODS 
 
2.1 NATURE OF THE STUDY. 
   This is a prospective descriptive hospital-based  study. 
2.2 STUDY AREA. 
       The study was conducted at the special care baby unit (SCBU) in    
Omdurman Maternity Hospital which is the busiest  maternity 
hospital in Sudan, with an average of 18000 deliveries per year . 
The average yearly nursery admission rate is estimated around 
1400 newborns which constitutes around (07.7%) of the delivery.  
2.3 STUDY DURATION. 
    This study was  conducted during the period from June 2005 till   
August 2005.  
2.4 STUYD POPULATION. 
       The study population included all preterm infants admitted for 
whatever reason to the SCBU in Omdurman Maternity Hospital 
during the study period.  
  
 
2.5 INCLUSION CRITERIA. 
       Any  newborn infant less than 37 weeks of gestation was to be 
included in the study.  
2.6 EXCLUSION CRITERIA. 
• Infants of parents who refused to be enrolled in the study. 
• Infants who died within the first six hours from admission. 
2.7 SAMPLE SIZE. 
       The sample size was calculated according to the equation below : 
                  N =  z2 x pq 
   d2e 
 
where 
      N = Sample size  
      Z = Statistical certainty 1.96( at 95% of confidence) 
       P = Prevalence = 5% 
       Q = Probability of failure at 95%  
       D = Desired margin of error = 0.05 
       Accordingly, the sample size as calculated to be 69 preterm 
infants. 
 2.8. METHODS. 
     2.8.1. Questionnaire :  
       A pre-coded structured questionnaire was filled  and it       
included  the following: 
• Socio-demographic background. 
• Family history. 
• Maternal and pregnancy history with emphasis on  maternal 
medications and type of delivery.  
• Apgar scores and resuscitative efforts offered to the baby. 
• Clinical examination including birth weight, gestational age 
assessment using the Ballard score, cause of admission and a 
detailed systems examination  (Annex I ).  
2.8.2.  Progress Sheet :  
          This was attached to every infant’s admission sheet 
immediately upon admission. It contained  serial records of vital 
signs, abnormal physical signs, medications given. Additionally, 
serial measurements of blood glucose, routine investigations and 
any interventions undertaken were also documented. Filling in of  
this data  was continued until 72 hrs of age or death of the baby 
(Annex 2).  
 2.8.3.    Accu-Chek Active® glucometer (Roche). 
              This is an easy-to use device for quick measurement of 
blood glucose. It is  manufactured by Roche Diagnostics Company 
(Switzerland). According to the manufacturer, it gives an error 
margin of ± 5mg/dL. The method of use involves the addition of one 
drop of blood from the patient in the specified area. The result will 
be obtained within few seconds. The device was calibrated every 25 
strips-cycle using a different code number per cycle.    
 2.9.DEFINITION OF TERMS. 
       The following  WHO definitions were adopted :- 
2.9.1.Early Neonatal Glycemic  Status:                                                           
Blood glucose level during the first 72 hours of life.  
2.9.2. Neonatal Normoglycemia : 
Blood glucose level between 46 mg/dl (2.6mmol/l) and 
125 mg/dl (7mmol/l). 
       2.9.3. Neonatal Hypoglycemia:  
                Blood glucose level  equal to or less than 46 mg/dl 
                (2.6mmol/l).  
       2.9.4. Neonatal Hyperglycemia  
    Blood glucose level equal to or more than 125mg/dL 
(7mmol/L)    with or without glucsuria.  
2.9.5. Small for Gestational Age (SGA): 
               Birth weight below the l0th percentile for infants of the same  
gestational age in the same population (1, 34).                                              
2.10. INTERVENTION. 
             As soon as infants were admitted , the questionnaire and    the 
progress sheet were filled. Serial blood glucose measurements using a 
standardized Accu-Chek® glucometer (Roche) by at 1,2, 6, 12, 18, 24, 
36, 48, 60 and 72 hours of age were taken. Blood was collected by the 
heelstick method. The inner area of the heal was selected, after being 
pre-cleansed by an appropriate antiseptic. Any further measurements 
ordered by the resident  and/or the  consultant in charge were also 
considered. Most of the  abnormal results (i.e. hypo or hyperglycemia) 
were confirmed by an immediate laboratory measurement of random 
blood glucose using the hexokinase enzyme method.                 
 
2.11. STATISTICS. 
         Data was computed, processed  and analyzed using Statistical 
Package for Social Sciences (SPSS)  computer software  programme. 
Chi-square test was used to compare the differences between cohorts. 
The test was considered significant at a confidence interval of 95%. P 
value was set at <0.05.  
2.12. RSEEARCH TEAM. 
• The author. 
• Six medical officers covering night shifts at the SCBU in 
Omdurman Maternity Hospital. 
2.13. ETHICAL CONSIDERATIONS. 
• Written consent from the hospital administration was taken.  
• Informed consent from the parents. 
• Informed consent from the consultants of the unit. 
• Any abnormal results were promptly  notified to the resident 
and or the consultant in charge to take an immediate action if 
necessary. 
2.14. DIFFICULTIES ENCOUNTERED. 
• Non availability of lab technicians during some night shifts. 
• None availability or loss of some data especially that concerning 
antenatal care or other old records especially in case of 
previous neonatal problems.  
 
 
2.15. OTHER PARTICIPANTS. 
• Sisters and nurses working in the nursery in Omdurman 
Maternity Hospital. 



















       
 
         In this study, a total of eighty two newborn preterm infants were 
enrolled . Four more infants were excluded because some of their data 
was missing.  
3.1. DEMOGRAPHIC AND SOCIAL CHARECTERISTICS 
OF THE STUDY GROUP. 
      3.1.1. Gender Distribution of the Study Group. 
              There was an obvious male predominance among the studied 
group. Forty eight were males comprising (58.5%) of the sample size, 
whereas females were 34 (41.5%). The male to female ratio was 1.4:1 
(Figure. 1).  No case of intersex was encountered.  
      3.1.2. Parent’s Occupation. 
                Concerning the mothers` occupations, 64 (78%) mothers 
were housewives. Ten were low-scale businesswomen  ( mostly tea 
and food sellers) constituting (12.2%) of the mothers. Six (07.4%) of 
the mothers were professionals and only two (02.4%) were skilled 
labourers (Figure. 2). 
 
 
































           Among infants` fathers, 24 (29.2%) were low-scale 
businessmen in contrast to 10 (12.2%) who were businessmen. 
Eighteen  of the fathers (22.0%) were professionals ,mostly 
teachers, lawyers, doctors and clerks . Labourers were 20 (24.4%). 
Of these, eight fathers (09.8%)   were skilled labourers compared to 
12 fathers  (14.6%) who were unskilled labourers . Ten fathers 
(12.2%) were unemployed at the time of the study (Figure 3). 
 
3.2. CHARECTERISTICS OF THE FAMILY HISTORY.  
       3.2.1. Parents` Consanguinity. 
                Regarding the  consanguinity among the parents of 
infants of the study group, thirty two parents (39%) were non-
consanguineous. Slightly greater than this; thirty six parents (43.9%)  
were first-degree cousins compared to 14parents (17%)  who were 
second degree cousins or far relatives (Figure 4).  
       3.2.2. Mothers` Parity. 
                Primiparous mothers were 26 constituting (31.7%). 
Likewise,  those who had 3 to 4 previous pregnancies had the same 
frequency. Those with 1 to 2 previous pregnancies were 10 
(12.2%). Mothers who had 5 or more previous pregnancies were 20 
(24.4%) as shown in Figure 5. 








Professional Businessman Low-scale businessman
Skilled labourer Unskilled labourer Unemployed
 
   Figure 4: Consanguinity Among Parents of the Study Group.  
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3.2.3. Previous Neonatal Problems. 
                Among families of the study group, Fifty two families 
(63.4%) had no history of previous neonatal problems. Another 
sixteen (19.5%) had had history of a serious neonatal illness 
necessitating hospital admission. Unfortunately, most of these were 
not precisely known. Fourteen families (17.1%) had experienced  
death of a neonate which was in most of the cases an early event 
(Figure 6). 
       3.2.4. Mother’s Known Medical Problems. 
                Among the study group mothers, fifty nine (71.9%) were 
without any known medical problems. Bronchial Asthma was  the 
mostly encountered problem; being reported by 10 mothers 
(12.2%). Second in order was diabetes mellitus which was seen in 
eight mothers (09.8%). Heart disease was seen in two mothers 
(02.4%), while other diseases as shown in table 1 were observed in 
three mothers (03.7%). Those were namely; hepatitis, 
hypothyroidism and essential hypertension (Table 1).


























 Table 1: Known Maternal Medical Problems. 
Known Problem Number Percentage 
None 59 71.9 
Diabetes Mellitus 08 09.8 
Bronchial Asthma 10 12.2 
Heart Disease 02 02.4 
Others  03 03.7 









 3.3.CHARECTERISTICS OF THE CURRENT 
PREGNANCY   AND LABOUR. 
      3.3.1. Obstetrical Complications During Current 
Pregnancy. 
                 Regarding obstetrical complications observed during 
current pregnancy, no complication was reported in 42 mothers 
(51.2%). In fifteen of them(18.2%), pregnancy induced 
hypertension was diagnosed ranking as the most frequent 
complication seen. Next  in  order was prolonged rupture of the 
membranes which was seen in seven  mothers (08.5%). 
Antepartum haemorrhage was diagnosed in five mothers (06.1%). 
Malaria and urinary tract infections accounted for 03.7 and 03.6% 
respectively.  
                Gestational diabetes ranked lower in the list occurring in 
only two mothers (02.4%). Amniotic fluid abnormalities (i.e. 
poly/oligohydramnios) were reported in only three mothers (3.7%). 
In two other mothers, antiphospholipid syndrome was diagnosed in 




Table 2: Obstetrical Complications Observed During the Current 
               Pregnancy. 
 
Complication  Number Percentage 
None  42 51.2 
Pregnancy Induced Hypertension/Eclampsia 15 18.2 
Gestational Diabetes 02 02.4 
Poly/oligohydramnios  03 03.7 
Prolonged Rupture of Membranes 07 08.5 
Malaria (prior to delivery) 03 03.7 
Antepartum Haemorrhage  05 06.1 
UTI 03 03.6 
Others 02 02.4 
Total  82 100.0 
 
3.3.2. Mode of Delivery.  
              The most frequent mode of delivery observed was 
vaginal; either spontaneous or induced. Almost  two  thirds  of the 
study group  were delivered  this way (68.3%). On the other hand, 
only two infants (02.4%) were delivered by forceps. A total of 24 
infants (29.3%) were the outcome of Caesarian sections. Two 
thirds of them (19.5%) were delivered by emergency sections 
(Table 3). 
       3.3.3. Type of Pregnancy.   
                Most of the infants were the outcome of singleton 
pregnancies. Seventy two  infants (87.8%) were singletons, while 
the remaining 10 infants (12.2%) were twins. It is worth mentioning 
that  no  triplets  were encountered  during the  study period ( 
Figure 7). 
       3.3.4 Maternal Medications. 
                Medications given to the mothers prior to delivery were 
studied. Dextrose / dextrose saline infusions were the mostly 
administered, being given to 36 mothers (43.9%). Dexamethasone 
was given to six mothers(07.3%). Eight mothers (09.8%) were 
given 
Table 3: Modes of Delivery of the infants of the Study Group. 
 
Mode  Frequency Percentage 
Vaginal delivery 56 (68.3%) 
Forceps delivery 02 (02.4%) 
Elective C/S 08 (09.8%) 
Emergency C/S 16 (19.5%) 
































miscellaneous types of drugs, namely antihypertensives, antibiotics, 
oxytocin and  salbutamol. The rest of the 32 mothers did not receive 
medications of any kind (39%) as shown in Table 4. 
 
3.4. INFANTS` CLINICAL ASSESMENT AND PROGRESS  
      3.4.1. Apgar Score and Resuscitation at Birth.  
              The Apgar score at five minutes was assessed in every 
infant. Those who scored less than 4 were 20 infants (24.4%). 
Twenty four infants (29.3%) had had a score between 4-7. An Apgar 
score of 8 or more was recorded in 38 infants (46.3%) as shown in  
Figure 8. 
             The resuscitative efforts offered to every infant were also 
documented. Forty eight infants (58.5%) needed only warming, 
drying and stimulation. Another twenty infants (24.6%) did not 
improve with that and needed bag and mask ventilation. Those who 
were more compromised at birth and needed additional chest 
compression were 10 newborns (12.7%). Intubation was performed 
in four newborn infants (05%) as shown in  Figure 9.  
 
 
Table 4: Medications Given to Mothers Prior to Delivery. 
 
Medication  Frequency Percentage 
None  32 (39.0%) 
Dextrose infusion 36 (43.9%) 
Dexamethasone  06 (07.3%) 
Miscellaneous   08 (09.8%) 




















0 5 10 15 20 25 30 35 40
Frequency
Apgar score 0-3 Apgar score 4-7 Apgar score 8-10
 
 






3.4.2.Birth Weights, Gestational Age Assessment and   Weight   
for Gestational age : 
              Among this study group, 14 newborns (17.1%) were 
extremely low birth weight (i.e. <1000g). The rest of the group was 
equally divided between birth weights of 1000-1500g who were 34  
infants (41.5%)  and  more than1500g who were of the same 
number and percentage  (Table 5).  
             Infants gestational ages were clustered into groups. The 
minority of  infants who were 12 (14.6%)  had gestational age  that 
was less than 28 weeks.  In contrast, the majority of infants who 
were 32 (39%) clustered in  the gestational age group 30-34 
weeks. Eighteen (22%) were between 28-30 weeks while twenty 
(24.4%) were between 34 to less than 37 weeks (Table 6). 
              The birth weights were compared with the gestational 
ages of the infants. Fifty infants, comprising more than half of the 
infants (61%), were appropriate for gestation (AGA). Twenty of 
them (25%), were small for gestation (SGA). Large for gestation 
(LGA) infants were 10 (12%) as shown in (Figure 10). 
 
Table 5: Distribution of the Study Group According to  Birth   
Weight. 
 
Birth Weight (g) Frequency Percentage 
<1000 14 (17.0%) 
1000-1500 34 (41.5%) 
>1500 34 (41.5%) 










Table 6: Distribution of the Study Group According to  
Gestational     Age Assessment . 
 
Gestational age(wks) Frequency Percentage 
<28  12 (14.6%) 
28-30  18 (22.0%) 
30-34 32 (39.0%) 
34-37 20 (24.4%) 













       3.4.3. Early Clinical Problems and Progress. 
              The most frequently diagnosed complication of prematurity 
among the study group during the first 72 hours of life was 
respiratory distress syndrome (RDS). This was observed in 50 
infants (54.9%) who comprised more than half of the study group. 
As expected, an  observable inverse relationship was found 
between the gestational age and the clinical severity of  (RDS) as 
shown in  table7.  
            Next in frequency was jaundice which was observed in 34 
infants (41.5%).In all of the infants this was presumably physiologic. 
In 24 infants (29.5%) hypothermia was documented. Early sepsis 
was clinically suspected  in nine infants(10.9%). In five infants 
(06%) the diagnosis of intraventricular hemorrhage (IVH) was 
considered based upon  the finding of bloody post-mortem 
ventricular taps. Chromosomal anomalies were diagnosed clinically 
in two infants (2.4%): one with features of Edward’s syndrome and 
the other with Down syndrome. Other problems encountered were 
as follows:  polycythemia  in  eight  infants   (09.7%),   disseminated  
 
 
Table 7: Clinical Severity of RDS in Relation to  the 
Gestational   Age. 
 






with RDS  No. % No. % 
<28 12 02   (16.6%) 10   (83.4%) 
28-30 12 06   (50.0%) 06   (50.0%) 
30-34 17 12   (70.6%) 05   (29.4%) 
34-37 05 04   (80.0%) 01   (20.0%) 







 intravascular coagulopathy in seven infants (08.5%) and necrotizing 
enteroclitis in two infants (02.4%) as shown in  figure 11.   
     3.4.4. Medications Given to the Study Group  
               The types of medications given to the infants during the 
first 72 hours were recorded. All the infants received intravenous 
antibiotics and a single prophylactic dose of intramuscular vitamin 
K as part of the  routine care offered in the nursery. All of the 
infants in the study group were started on intravenous dextrose as 
soon as they were admitted.  According  to  the  policy   in the    
nursery,  the fourteen infants (17%) whose birth weights were less 
than 1000g  were  given   intravenous   dextrose 5%  solution. 
                The  rest   of  the  study  group  who were  68  (83%)  
were  started on dextrose 10% infusion. Aminophylline was 
administered to 20 infants (24.4%). Epinephrine was less used  

































Table 8 : Types of Drugs Given to Infants of the Study 
Group During the First 72 hours  of life. 
 
Drug  Number of 
infants 
Percentage 
Dextrose 10% 68 (83%) 
Dextrose 5% 14 (17%) 




Aminophylline 20 (24.4%) 







        3.4.5. Feeding.  
                 The ages in hours at which infants were offered the first 
feed were documented. In the majority of infants who were 39 
(48%), feeding was not started until 72 hrs of age. Feeding was 
started after less than 12 hours of age in only eight infants (10%). In 
a similar proportion, feeding was delayed until 24 hours. In fourteen 
infants (17%), feeding was commenced between 24 to 48 hours.  
Infants who had their feeding started between 48 to 72 hours were 
12 and represented (15%) of the study group (Figure 12). 
                    The type of the first feed was also studied. It was found 
that 39 infants  (47.5%) had breast milk (whether expressed or 
directly from the mother) as their first feed.  Formula milk was 
offered as the first feed to 24 infants (28.8%). Oral glucose was the 



























    Figure 13: Types of the initial feeds that were given during the first 72 hours.  




Breastmilk Oral glucose Formula milk
3.5. IMMEDIATE OUCOME OF THE STUDY GROUP. 
         Infants of the study group were followed up until 72 hours of 
age and the different patterns of their outcome were documented. 
Twenty eight infants (34.1%) were discharged  well from the 
nursery  within the first three days. Another 26 infants (31.8%) 
stayed  in hospital beyond 72 hours while death occurred in 28 
infants giving a rate of 34.1% (Table 9).  
 Respiratory distress syndrome (RDS) was the leading 
cause of mortality among the infants of the study group accounting 
for 67 of the deaths  (82%). Although other direct possible causes 
of death were documented, yet,  they could have possibly been 
regarded in part as complications of RDS. Thus, RDS as a sole 
cause of death was encountered in ten infants (35.7%). 
Disseminated intravascular coagulopathy (DIC) was the direct 
cause of death in seven infants (25%). Intraventricular 
hemorrhage, which was retrospectively diagnosed by postmortem 
ventricular taps, occurred in five infants (17.8%). Early sepsis, 
diagnosed on clinical grounds, probably   had  led  to  the  death of  
 
 
Table 9: Different patterns of the outcome  of the study group 
within the first 72 hours of life. 
 
Outcome  Frequency Percentage 
Discharged home well 28 (34.1%) 
Remained in hospital  26 (31.8%) 
Died  28 (34.1%) 











Table 10: Possible direct causes of death among the study        
  group. 
Possible Cause Number Percentage 
(RDS) 10 (35.7%) 
(DIC)  07 (25.0%) 
(IVH) 05 (17.8%) 
Early sepsis 04 (14.3%) 
Necrotizing Enterocolitis 02 (07.2%) 






 four infants (14.3%). Two infants (07.2%) died of necrotizing 
enterocolitis (Table 10). 
          The patterns of outcome were further analyzed in relation to 
the different categories of birth weight. Infants whose birth weights 
were less than 1000g had the poorest outcomes. None were 
discharged home, in fact; four  of them ( 28.6%) remained in 
hospital and the other ten (71.4%) died. A notable improvement in 
the outcome occurred in those who weighed between 1000 to 
1500g. Fourteen newborns (41.2%) were discharged well, 10 
(29.4%) remained in hospital while the other 10 (29.4%) died.  
           On the other hand, infants whose weights were more than 
1500 at birth had the best outcome. Only eight infants (23.5%) 
succumbed to death in the first 72 hours of life.  Fourteen infants 
(41.2%) were discharged well and another 12 (35.3%) remained in 





 Table 11 : Patterns of  the Outcome of the Study Group in 
Relation to Birth Weight.        










No. % No. % No. % 
Total 
No. 
<1000 00  (00.0%) 04   (28.6%) 10  (71.4%) 14 
1000-
1500 
14 (41.2%) 10   (29.4%) 10  (29.4%) 34 
>1500 14  (41.2%) 12   (35.3%) 08  (23.5%) 34 







3.6.GLYCEMIC STATUS OF THE STUDY GROUP.  
       Serial blood samples were taken to determine the glucose 
levels at different time during the first 72 hours of life. A total of  
734 samples were taken during the study period with an average 
of 8.9 samples per infant. The total number of samples taken on 
day I was 492 accounting for (67%) of the samples. On the second 
and third day, samples taken were 143 (19.5%) and 99 (13.5%), 
respectively.  
      3.6.1. Prevalence of Hypo and Hyperglycemia Among the 
Study   Group. 
              In every single newborn preterm infant, any single hypo or 
hyperglycemic event was considered. Thus, hypoglycemia was 
detected in 38 infants (46.8%). Comparatively, hyperglycemia was 
less prevalent being observed in only 20 infants giving a percentage 
of (24.4%) as shown in figure 14. The frequencies of hypo and 
hyperglycemia were further analyzed in view of their time of 
occurrence. Day I witnessed the highest frequency of glycaemic 
derangements. Hypoglycemia was reported in 82 (16.6%) samples   
 
 
of the total samples taken on that day, while hyperglycemia was 
documented in 46 samples (09.3%). Day II witnessed a remarkable 
improvement. Hypoglycemia was reported in only 14 samples 
(09.7%), whereas hyperglycemia was reported in 16 samples giving  
a percentage of (11.1%). On day III, no hypoglycemic event was 
reported while hyperglycemia was detected in only two samples 
(02%) as shown in figure 15.  
3.6.2. Correlation of Hypo and hyperglycemia with Different    
Variables.  
        3.6.2.1. Correlation with Gender:  
                     Among the whole study group, hypoglycemia was more 
prevalent in females occurring in 43 female newborns (52.6%) 
compared to (47.4%) occurring in the males. This difference, 
however, was not statistically significant ( P = 0.177).  In contrast,  
hyperglycemia was more common among males. Twelve of those 
affected (60%) were males as opposed to 8 females (40%). This 
difference  was statistically significant (P< .001).  The male: female 
ratio was estimated to be 1.5:1 as shown in Table 12. 




























         
Figure 15: Frequency of hypo and hyperglycemia among samples taken during the first three 
















Day IIIDay II Day I 
Hypoglycemia Hyperglycemia
 
 Table 12: Distribution of hypo and hyperglycemia cases in  
                 relation  to gender. 
 
 
      








Hypoglycemia Hyperglycemia  
Gender No. % No. % 
Male 18 (47.4%) 12 (60.0%) 
Female  20 (52.6%) 08 (40.0%) 
Total 38 (100.%) 20 (100.%) 
 
3.6.2.2. Correlation with Birth Weight and Gestational Age :  
                   The frequency of hypoglycemia as well as hyperglycemia, 
was clearly found to be inversely  proportionate to the   birth weights of 
 the study group. Among infants who weighed less than 1000 g at birth, 
12 of them (85.7%) developed hypoglycemia at one point or another 
during the first three days. Eight of them (57.1%) , also manifested one 
or more episodes of hyperglycemia. Those whose birth weights were 
between 1000-1500g, developed both hypoglycemia and 
hyperglycemia at a rate of (41.1%) and (29.4%) respectively.  
         Infants of birth weights more than 1500g did better. 
Hypoglycemia was seen in 12 of them (35.9%), whereas 
hyperglycemia was evident in only two infants (05.9%). Lower birth 
weights were thus  statistically significantly associated with 
hypoglycemia (P< 0.046) and hyperglycemia (P< 0.001) as shown in 
figure 16. 
         A remarkable correlation was also observed between the 
gestational age and  glycemic derangements.  Infants less than 28 
weeks gestation were mostly affected. Hypoglycemia was observed in 
(83.3%) of this  group while hyperglycemia occurred in (66.7%). 
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In those whose gestational ages were between 28 to 30 weeks, 
hypoglycemia occurred at a rate of (61.1%), whereas hyperglycemia 
was observed at a rate of (38.9%). These rates fell down to (40.6%) 
and (12.5%) respectively, in those between 30 to 34 weeks of 
gestation. Finally, in the age group 34 to 37 weeks, hypoglycemia 
was found in (20.1%) of the infants, while the  rate for 
hyperglycemia continued to decline reaching down to only (05%) as 
shown in table 13.  From a statistical point of  view,  these  
observations were found to be highly significant for hypoglycemia 
(P< 0.002) as well as for hyperglycemia (P< 0.01).         
          Concerning the early glycemic derangements relevant to the 
weight for gestation, infants who were small for gestation (SGA) 
were found to be mostly affected. Hypoglycemia occurred in 14 of 
these infants (63.6%). In comparison, in infants who were (AGA), 
hypoglycemia was detected in  22 of them (44.0%).  Infants who 
were (LGA) had had hypoglycemia detected in (20.0%) of them. 
These differences when tested, were found to be highly significant 
(P<0.0001). On the other hand, hyperglycemia occurred in eight of 
the infants (36.6%) who were (SGA) compared to 12 infants (24%)in  
 
Table 13: Correlation of hypo and hyperglycemia with the 
different   gestational ages of the study group. 
 
Hypoglycemia Hyperglycemia Gestational 
Age (wks) 
No. Percentage No.  Percentage  
< 28 10 (83.3%) 08 (66.7%) 
28-30 11 (61.1%) 07 (38.9%) 
30-34 13 (40.6%) 04 (12.5%) 
34-37 04 (20.0%) 01 (05.0%) 
Total  38 - 20 - 
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 the   group of  (AGA)   infants  (Figure 17). This   difference  was   
of This difference was of statistical significance ( P< 0.001). Notably, 
none of the (LGA) infants had had hyperglycemia.  
3.6.2.3. Correlation With the Family and Birth History : 
                 Early hypo and hyperglycemia were analyzed in relation 
to the different  variables of the family and birth history. Infants born 
to consanguineous parents had the highest percentage of 
hypoglycemia which was evident in 21 infants (61.1%). However, 
that was not the case for hyperglycemia which was detected in only 
four infants (11.1%). The result was statistically  significant for 
hypoglycemia (P<0.03), while not for hyperglycemia (P=0.673).  
               The correlation with maternal medical problems was 
studied. Maternal diabetes was strongly associated with 
hypoglycemia which was observed in (55.5%) of the infants whose 
mothers had had the disease (P< 0.001). In comparison, all infants 
who were born to mothers with gestational diabetes developed 
hypoglycemia.  Other maternal and obstetrical problems were not 
associated with glycemic derangements. None of the maternal 
medications  was associated  neither,  except  for maternal dextrose  
 
infusions . Hypo and hyperglycemia were concurrently observed in 
20 (55.5%) and in 15 (43.2%) of the infants born to these mothers 
respectively. Consequently, maternal pre-medication with dextrose 
infusions was found to be associated with neonatal hyperglycemia 
(P< 0.021), rather than hypoglycemia (P=0.403).  The relationship 
between mother’s parity and hypo and hyperglycemia was 
statistically tested. No statistically significant difference was found 
between the parities of the mothers (P=0.314).                                               
        When taking the mode of delivery into account, it was found 
that 26 (46.4%) of the infants who were delivered vaginally              
(whether spontaneous or induced) developed hypoglycemia, 
together with another 20 infants (35.7%) in whom hyperglycemia 
was detected. The percentage of hypoglycemia was much higher in 
those who were delivered by emergency  caesarian  sections  than 
in those  delivered  by  elective sections ( 75%) versus (00%). This 
difference was statistically significant (P<0.037). Similarly, 
hyperglycemia was observed in all (100%) those who were 
delivered by emergency sections (P< 0.0001) as shown in table14. 
         The glycemic status of the study group was further assessed 
in view of the Apgar score at 5 minutes. In infants whose scores  
 
Table 14: Correlation of hypo and hyperglycemia with the 
different modes of delivery of the study group. 
 
Hypoglycemia Hyperglycemia  
Mode of Delivery No. % No. % 
Vaginal delivery 26 (46.4%) 20 (35.7%) 











were 3 or less, hypoglycemia was more prevalent being  detected in 
14 out of 20 infants  (70%). In those who   scored 4 to 7  and those  
8 to  10,  hypoglycemia  was  seen in  ten  infants  (42.1%), and  in 
12 infants (33.1%) respectively. These differences were statistically 
significant (P <0.0001). The same findings were seen as far as 
hyperglycemia was concerned. It occurred more commonly among 
infants with the scores between 0-3, being detected in six infants 
(31.6%). Those who scored between 4 to 7, had had hyperglycemia 
in five of them at a rate of (20%). Scores between 8 to 10 were 
associated with hyperglycemia at a lower rate being detected in six 
infants (16.7%) as demonstrated in figure 18. Again, these 
differences were of statistical significance (P<0.02).  
       The level of  resuscitation  offered  at birth  was  also examined. 
The more the need  for resuscitation , the  higher  the  prevalence of  
both hypo and hyperglycemia. In infants who needed bag and mask 
ventilation at birth,  hypoglycemia  was  reported  in  ten of  them  
(50%), whereas hyperglycemia occurred  in four (20%) of this 
cohort. In five of the more compromised (50%) infants who needed 
additional chest  compression ,  hypoglycemia  was detected 
Figure 18 : Correlation between Apgar score at 5 minutes and the early glycemic  
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             (P<0.02) 
 
Figure 19 : Correlation between levels of resuscitation offered t birth and the glycemic 
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Hyperglycemia was documented in all of them. When intubation 
was indicated, hypoglycemia was found in three out of four (75%), 
and hyperglycemia in two out of four (50%), as shown in figure 19. 
These findings were statistically significant for both states: 
(P<0.002) for hypoglycemia, and (P< 0.021) for hyperglycemia. 
3.6.2.4.Correlation with Early Clinical Problems and 
             Progress : 
                Estimates of hypo and hyperglycemia were analyzed 
against different clinical problems encountered during the first 72 
hours of life. Infants with (RDS) were studied in view of their 
glycemic status. Of  the 50 infants with (RDS), hypoglycemia was 
detected in 28 infants comprising (56%) of them (P<0.02).  
Hyperglycemia was detected in 16 infants (32%) with RDS  
(P=0.15) . In conclusion, RDS was causally related to hypoglycemia 
but not to hyperglycemia (figure 20). 
               Other early problems were also cross tabulated with 
hypo and hyperglycemia respectively. Among the 24 infants in 
whom one more events of hypothermia were detected, 
hypoglycemia   was  reported  in 16 (66.7%) of     them     whereas  
 
 
hyperglycemia was reported in  four infants (16.7%). This 
correlation was statistically significant for hypoglycemia ( P <0.01) 
but not for hyperglycemia (P= 0.63). 
             In infants who were suspected  to  be  septic, hypoglycemia 
occurred in one third (33.3%) of these infants (P=0.64). In contrast, 
hyperglycemia was detected at in five of the infants (55.5%) of this 
group (P<0.002).This showed that sepsis was a statistically 
significant independent variable  for hyperglycemia but not for 
hypoglycemia. In five infants (73.1%) of those  who developed DIC 
in their early course, hypoglycemia was detected (P<0.001), while 
hyperglycemia was seen in four (57.1%) of them (P<0.01). When 
polycythemia was considered, hypoglycemia was reported in two 
infants (25%). This was not statistically significant (P=0.52). 
Hyperglycemia was observed in none of the polycythemic infants. 
Contrary to this,  in infants in whom a diagnosis of IVH was made, 
hyperglycemia predominated. This was observed in four infants 
(80%) out the five with the condition (P<0.001).  Hypoglycemia, on 
the other hand, was seen in only two infants ( 40%), as shown in 
figure (20).      
 
    Figure 20 : Correlation of hypo and hyperglycemia with some of the clinical problems 




































      3.6.2.5. Correlations with Medications and Feeding : 
                  Among the 68 newborn preterm infants who were given 
dextrose 10% solution, hyperglycemia was detected in 30 infants 
(44.4%) of them (P=0.74). Likewise, hypoglycemia was observed in 
29 infants (43.3%) of the same population (P=0.39). In comparison, 
those who were given dextrose 5% solution had had hyperglycemia  
in nine (66.7%) of them (P<0.009). Among this cohort, 
hypoglycemia was detected in 12 (83.3%) out of the fourteen infants 
(P<0.049). Accordingly, administration of dextrose5% solution was 
statistically significantly associated with a higher incidence for both 
hypo and hyperglycemia, whereas administration of dextrose 10% 
was not (figure 21).  In infants in whom aminophylline was 
administered,  hypoglycemia was found in (70%) of them. This 
finding was not statistically significant (P=0.084). In contrast, the 
incidence of hyperglycemia in those who were given aminophylline, 
though not as high as that of hypoglycemia (50%), was statistically 
significant (P<0.03). Thus, aminophylline was found to be a risk 
factor for hyperglycemia but not of hypoglycemia among  the study 
group (figure 21).  
 
Figure 21 : Incidence of hypo and hyperglycemia in relation to aminophylline and the 
































                As far as the age of  initiation of feeding was concerned, 
hypoglycemia was observed in (25%, 25%, 14.3%, 33.3% and 70%) 
in those in whom feeding was started at less than 12, between 12-24, 
between 24-48 , between 48-72 and not until 72 hours of age 
respectively (P<0.047). Similarly, hyperglycemia occurred in (25%, 
00%,00%, 33,3% and 35%) respectively, of that  cohort  (P<0.28), as  
shown  in  figure 22. 
3.6.3.Correlation of the Glycemic Derangements with the   
Patterns of the Outcome of the Study Group: 
              The different short term outcome within the study group 
were analyzed in regard to the glycemic status observed in each 
cohort. Of the 28 infants who were discharged within the first 72 
hours, only two (07.1%) of them experienced hypoglycemia, while 
none had had hyperglycemia. In the group who stayed in the nursery 
beyond 72 hours hypoglycemia occurred in 18 infants (69.2%) and 
hyperglycemia in eight (30.8%). In eighteen infants ( 64.3%) who died 
hypoglycemia was reported (P<0.025). Hyperglycemia occurred less 
frequently among those who died being observed in 12 infants 
representing (42.9%) of that cohort (P<0.001). These findings were of 
statistical difference (Table 15). 
 
Figure 22 : Different ages(in hours) at which feeding was started in relation to hypo and 
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Table 15 : Correlation of the Immediate Outcome of the Study 
Group with the Glycemic Derangements  Detected.  
 




No.  % No.  % 
Discharged  28 02 (07.1%) 00 (0.0%) 
Remained in 
hospital  
26 18 (69.2%) 8 (30.8%) 
Died  28 18 (64.3%) 12 (42.9%) 




4.1 DEMOGRAPHIC AND SOCIAL CHARCTERISTICS OF 
THE STUDY GROUP. 
      A total of 82 newborn preterm infants who were admitted in the 
special care baby unit at Omdurman Maternity Hospital   were studied 
during the   period from July to August 2005.   
      4.1.1. Gender Distribution of the Study Group: 
              Males predominated among the study group comprising 
(58.5%), whereas females constituted (41.5%). The male to female ratio 
was estimated to be 1.4:1. These findings were very similar to what 
Sarah A. Salih had found in her study on the early neonatal outcome of 
preterm infants admitted in Soba University Hospital. The male to female 
ratio in that study was  found to be 1.2:1 (78). 
       4.1.2. Parent’s Occupations: 
           The parents` occupations were studied in order to describe the 
different socio-economic backgrounds of the study group. Most of the 
mothers were housewives (78%), while the rest were low-scale 
businesswomen (12.2%), professionals (07.4%) and skilled labourers 
(02.4%).  On the  other hand,  most of  the fathers  were    low-scale  
 
businessmen (29.2%). Professionals comprised (22%) of the fathers, 
while skilled labourers, unskilled labourers and unemployed fathers 
comprised (09.8%), (14.6%) and (12.2%) respectively. Thus, most of the 
infants of the study group were from low socioeconomic backgrounds. 
This is with consistent with the well documented association of 
prematurity and  low socioeconomic status (2). Furthermore, Ventura et 
al from USA concluded that maternal and paternal jobs with lower 
economic rewards were more frequently associated with preterm labour 
than managerial and professional  jobs (79).  
4.2. CHARECTERISTICS OF THE FAMILY HISTORY: 
       4.2.1. Parents` Consanguinity: 
                      Consanguinity was prevalent in the study group parents. A 
higher percentage of first degree cousins was detected in (43.9%), while 
non-consanguineous parents comprised (39%) and second degree  or 
far relative-parents collectively comprised (16.1%). This could have 
affected the pattern of diseases observed among the study group by 
potentially increasing the incidence of autosomally recessive disorders. 
The best example  that  might  have  affected the  
 
metabolic status and the outcome of the study group is the group of the 
inborn errors of metabolism (80). However, none of these conditions 
among the study group, even if  suspected, were amenable to diagnosis 
because of the lack of facilities.    
         4.2.2. Mothers` Parity . 
                  There were two peaks for the frequency of previous 
pregnancies, primiparous mothers and those who had 3 or 4 
pregnancies before. Both groups  occurred at a relative frequency of 
31.7%. In comparison, mothers who had 5 or more previous 
pregnancies were 20 and comprised (24.4%) of the mothers. Despite 
the fact that prematurity is more prevalent in mothers who have more 
than 4 children, primiparous mothers represented a considerable bulk 
among the study group mothers(2). This discrepancy could be explained 
by the finding that most primigravidae in our setting are brought to be 
delivered at hospital in contrast to the multiparous mothers who would 
prefer to deliver at their homes. However, this finding was in accordance 
with the conclusion drawn by M.A Elemam in his study on the risk 
factors of preterm labour in Khartoum, Sudan.  Nulliparity, he concluded, 
was a significant risk of preterm labour in Sudanese women (81) .  
 
4.2.3. Previous Neonatal Problems.     
                    Among families of the study group, fifty two (63.4%) had no 
history of previous neonatal problems. Another sixteen (19.5%) had 
history of a serious neonatal illness necessitating hospital admission. 
Unfortunately, most of these were not precisely and adequately 
documented. Fourteen families (17.1%) had experienced  death of a 
neonate which was in most of the cases an early event. These relatively  
high figures could possibly be attributed to poor socioeconomic 
backgrounds that these families were from. Poor standards of living, the 
highly prevalent infections, short interpregnancy intervals and the high 
rate of consanguinity are all incriminated.  
           4.2.4. Mother’s Known Medical Problems: 
                    The majority of the mothers, who were 59 mothers (71.9%), 
were without known medical problems. Frequently reported problems 
were bronchial asthma and diabetes mellitus, being reported in ten 
mothers (12.2%) and eight mothers (09.8%) respectively. Other 
problems included heart disease, hepatitis, hypothyroidism  and  
essential  hypertension. These  chronic  medical  
problems with their known adverse effects on the fetal nutrition, could 
have possibly attributed to the relatively high incidence of small for 
gestation infants found in this study (1).  
 
 4.3.CHARECTERISTICS OF THE CURRENT PREGNANCY 
AND LBOUR. 
      4.3.1. Obstetrical Complications During Current Pregnancy: 
                  In over half of the mothers (51.2%), no obstetrical 
complications were observed. In the rest, pregnancy induced 
hypertension (PIH) was the most frequently encountered, being 
diagnosed in 15 mothers (18.2%). This finding was with an agreement 
with what many authors had arrived at.  The American College of 
Obstetricians and Gynecologists stated that PIH complicates (12%) to 
(22%) of all pregnancies (82) . Muna Babiker in her recent study on the 
risk factors of perinatal mortality in two hospitals in Khartoum, Sudan, 
demonstrated that (PIH) was a significant risk factor for preterm labour 
(83).  
                   Other encountered problems among mothers were: 
premature rupture  of the  membranes  (08.5%),  malaria  (03.6%)and 
urinary tract infection (07.3%), gestational diabetes (02.4%), amniotic 
fluid abnormalities (03.7%) and antiophospholipid syndrome (01.2%). All 
these have been described in the literature as risk factors of preterm 
labour as well as causes of uteroplacental insufficiency leading to 
intrauterine malnutrition and hence small for dates babies (2,79,82) .    
        4.3.2. Mode of Delivery:  
                Most of the infants in the study group were delivered vaginally 
(68.3%). Approximately one-fifth of them (19.5%) were delivered by  
emergency caesarian sections (EMCS). Only eight infants (09.8%) were 
delivered by elective sections and a minority of two were delivered by 
forceps (02.4%).   The predominance of the vaginal route was not 
surprising since most  of these mothers had just presented to hospital in 
advanced labour. The relatively higher incidence of (EMCS) is 
attributable to the commonly associated obstetrical complications which 
in most of the cases were genuine indications for the procedure.       
        4.3.3. Type of Pregnancy :   
           The  greater  majority  of the  infants  were  the  outcome   of  
singleton pregnancies (87.8%), while twins comprised (12.2%) of the 
study group. These findings were very similar to the  findings in the 
literature in regard to the prevalence of multiple pregnancy among the  
preterm population. Taffel in his report on health and demographic 
characteristics of twin pregnancy in the United States stated that 
multiple pregnancy accounted for (13%) of all births less than 37 weeks 
of gestation (84).  
          4.3.4. Maternal Medications : 
                  A considerable proportion of 36 mothers (43.9%) were given 
dextrose/dextrose saline solution immediately prior to delivery. This had 
reflected the routine practice of the obstetricians of administering 
intravenous solutions during their active management of labour. In fact, 
mothers who were not given fluids, are probably those who presented 
urgently in advanced labour. This postulation could also be considered 
to explain the small percentage (09.8%) of mothers who had received 
antenatal dexamethsone. Uncertainty of dates, frequently seen  among 
the mothers, was probably  an additional factor that might have 






4.4. INFANTS` CLINICAL ASSESMENT AND PROGRESS. 
             4.4.1. Apgar Scores and Resuscitation at Birth . 
 
                    A considerable proportion of 20 infants (24.4%) were born 
severely asphyxiated as determined by  their  low Apgar scores at 5 
minutes (<4).  Another 24 (29.2%) were moderately asphyxiated. It is 
worth mentioning  that prematurity is a well recognized cause of birth 
asphyxia due in part to surfactant deficiency (85) . In this study it had  
been observed that the lesser the birth weight, the lesser would be the 
Apgar scores. In this study, 48 infants (58.5%) received no active 
resuscitation whereas  20 infants (24.6%) needed bag and mask 
ventilation at birth. In ten infants (12.7%),  chest compression was 
needed in addition. These findings were to a lesser extent not consistent 
with Sara A. Salih`s figures. In her study,  (46%) of the preterm infants 
received no active resuscitation  while (15%) needed bag and mask 
ventilation (78).  Despite the fact that   a considerable number of the 
infants were compromised at birth, the intubation rate was very low 
compared to that reported in the study conducted by Ventura et al which 
was (05%) versus (60%). This could well be explained   by  the  
inexperience  of the   (SCBU) staff      but      more  
 
importantly by the non-availability of surfactant therapy and the lack of 
ventilatory support facilities.  
     4.4.2.Birth Weights, Gestational Age Assessment and Weight 
for Gestational age . 
                In this study group, 14 infants (17.1%) were of extremely low 
birth weight (i.e. <1000g). The rest of the group was equally divided 
between birth weights of 1000-1500g  and >1500g which was 34 infants 
each (41.5%). The incidence for the extremely low birth weight (ELBW) 
was slightly higher than that reported by Lemons et al in their study on 
the very low birth weight outcomes of the American National Institute of 
Child health and human development neonatal research network. They 
estimated that (ELBW)  occurred at a rate of 1 in each 10 infants(86)  .  
          The minority of  infants(14.6%) were less than 28 weeks 
gestation.  In contrast, the majority of infants(39%) clustered in  the 
gestational age group 30-34 weeks. Eighteen infants (22%) were 
between 28-30 weeks compared to 20 infants (24.4%) who were 
between 34 to less than 37 weeks. This distribution was similar to that 
obtained by Sara Salih and  Ventura  in their respective studies(78,79) .  
          
         More than half of the infants (61%) were appropriate for 
gestation(AGA). Twenty two infants (27%) were small for gestation 
(SGA). Another ten (12%) were found to be large for gestation (LGA). In 
comparison, Sara A. Salih found (61%) of her study group to be (AGA) 
infants. Moreover  (32%) were (SGA) and only (4%) of the infants were 
(LGA) newborns (78). The overrepresentation of (LGA) infants in my 
study might possibly be due to the higher frequency of uncontrolled 
diabetic mothers.  
        4.4.3. Early Clinical Problems and Progress. 
                 Respiratory distress syndrome (RDS) was the most frequently 
encountered  complication among the study group, being observed in 
(54.9%). This was in agreement with the fact that (RDS) is the most 
common complication of prematurity (2) .  It is to be stated that the figure 
obtained is higher than that reported in the literature. Whitsett et al 
estimated the incidence of (RDS) to be (14%) in all low birth weight 
infants in the United States (87) . According to the annual perinatal 
mortality report  for the year 2004 in Omdurman Maternity Hospital, 
(RDS) was documented in (42.2%) which was the most frequent  cause  
of  morbidity  in the preterm infants admitted there (4).  
 
 
The relatively higher figures in my study were probably due to the higher 
incidence of birth asphyxia coupled with lower rates of antenatal steroids 
use, both being risk factors for the condition (85).  
            Second in the list of early morbidity among the study group was 
jaundice which was seen in 43 infants (41.5%). In nearly all these, no 
identifiable direct cause was found, hence, all were labeled as jaundice 
of prematurity.  Although other risk factors such as sepsis, (RDS), and 
infants of diabetic mothers were described among these infants, it was 
difficult to link them causally. This observation was almost typical to 
what had been stated in the literature that while (40%) of term babies 
develop jaundice,  (60%)  of preterm  ones do so (2).   
           Hypothermia was documented in 24 infants (29.5%), a rate that 
contrasted with  what Sara A. Salih had found in her study which was 
only (03%). This discrepancy might be explained by the fact that there 
was a fewer number of incubators in our nursery coupled with the 
increased rates of admission. Secondly, and because of the  meticulous  
clinical monitoring of the infants used in my study, the chance of  
identifying  more hypothermic events  was increased.  
               
 
          Sepsis was clinically suspected  in (10.9%) of the study group. 
Lack of laboratory facilities had led to this. In five infants (06%) the 
diagnosis of intraventricular hemorrhage (IVH) was made on the basis of 
postmortem ventricular taps. In the report from the Neonatal Research 
Network in the United States, (IVH) occurred in (32%) of  (VLBW) infants 
and its severity mounted to grades III and IV in (11%) of that cohort (86). 
The findings obtained  from my study were notably  underestimates 
since the method of diagnosis used was rather insensitive and of low 
specificity as it obviously failed to diagnose  other grades of (IVH) 
namely grades I and II. Other problems encountered among the study 
group were diagnosed mainly upon clinical grounds in many instances 
because of non availability of the appropriate tools. Consequently, 
shortcomings were to be expected. Disseminated intravascular 
coagulopathy (DIC) was diagnosed in seven infants (08.5%), 
polycythemia in eight (09.7%), and necrotizing enteroclitis (NEC) in two 
infants (02.4%). Comparatively, (NEC) was reported to occur at a 
frequency  of (02%) to (10%) in all (VLBW) infants according to Lemons 
et al (86) .   
      
 
 
          4.4.4. Medications Given to the Study Group. 
               As part of the policy adopted in the (SCBU) at Omdurman 
Maternity Hospital, all  admitted newborn preterm infants were given 
parenteral antibiotics, intramuscular vitamin K and intravenous dextrose 
solutions. Among the study group, 68 infants (83%) were given dextrose 
10%, whereas the other 14 (17%) were given dextrose 5%. The criterion  
for  selecting the dextrose concentration was dependent upon the birth 
weight. According to the policy, those whose weights were less than 
1000 g were given dextrose 5%.  Apnoea of prematurity was treated 
with aminophylline in 20 infants (24.4%). Interestingly, this figure was 
very similar to what had been reported in the literature. Apnoea of 
prematurity is estimated to occur in approximately 25% of all preterm 
infants (86).  
   4.4.5. Feeding  
             This study had shown a general trend towards delayed feeding. 
Almost half the number of the  infants (48%) were not started on  
feeding until 72 hours of age. It could be hypothesized that the reason 
behind this was the high prevalence of (RDS) among the study group 
occurring in 50 infants  (54.9%),  which  had necessitated  
 
putting these infants on nothing by mouth for longer hours as part of 
their management plan. According to the current practice in the nursery, 
breast milk and oral glucose were the most popular feeds to start with. 
For financial reasons , formula milks were not affordable to many 
families and were given to only 24 infants (23.7%). 
 
4.5. IMMEDIATE OUCOME OF THE STUDY GROUP. 
       In this study group, the preterm mortality rate in the first 72 hours of 
life was (34.1%). This was consistent with the preterm mortality rates 
documented in the annual perinatal report of Omdurman Maternity 
Hospital for the years 2001-2004. These rates ranged between (52.8%) 
to (64.4%) over these years (4). It is worth mentioning that these rates 
had included deaths that occurred beyond three days. Moreover, 
(31.8%) of my study group stayed beyond the this period and their 
outcome was still to be determined. It could be stated that these high 
rates are mainly due to lack of intensive neonatal care facilities. In 
comparison, Muna B. Mohammed in her study on perinatal outcomes in 
Ibrahim Malik Hospital in Khartoum, Sudan, found that (55.3%) of the 
preterm infants delivered there had died. Furthermore, she concluded 
that prematurity carried 16 times the risk of mortality when compared to 
maturity (83).    
          Respiratory distress syndrome (RDS) was the leading cause of 
mortality among the study group being recorded in (82%) of the deaths. 
However, it is to be stated that other direct possible causes of death were 
documented although they could have possibly been regarded in part as 
complications of RDS. Thus, RDS as a sole cause of death was seen in 
10 cases (35.7%). This high figure is mainly attributable to the non-
availability of surfactant and ventilatory support equipment in the nursery.  
In comparison, Sara A. Salih found (RDS) to be the commonest cause of 
mortality among preterm infants in Soba University Hospital accounting 
for (46.2%) of the deaths (78).  
           The mortality rates and birth weights were inversely related in the 
study group. This was typically  the  case in almost all relevant studies (2, 
78, 82, 83, 86, 88). It had been agreed on by many authors that as birth weight 
increases from 500 to 3000 g,   a logarithmic decrease in  neonatal 
mortality occurs. And that for every week increase in gestational age from 
the 25th to the 37th week,  the  neonatal  mortality  rate decreases by  
approximately  one half     (86, 88).  
       
 
4.6.GLYCEMIC STATUS OF THE STUDY GROUP  
      4.6.1.Prevalence of Hypo and Hyperglycemia Among the Study   
Group. 
                   Hypoglycemia was detected in 38 infants (46.8%). This was 
consistent with the findings of other investigators. Thuraya M. Zein 
arrived at a slightly lower figure. Her estimated hypoglycemia rate 
among preterm infants was (38.7%) during the first 6 hours of life (76) . 
Internationally, Anderson et al, observed that hypoglycemia was present 
in (55%) of those weighing <2500 g born in Katmandu in  Nepal (40) . 
Other two studies from Finland and Italy estimated the prevalence of 
hypoglycemia among the preterm infants to be (42%) and (35%) 
respectively ( 39,26) .  
          On the other hand, hyperglycemia was less prevalent being 
observed in 20 infants giving a percentage of (24.4%). This was higher 
than what most of the other authors had arrived at.   For instance, 
Falcão et al   from Brazil detected hyperglycemia in (11.5%) of the 
samples taken in  their study  on 41  preterm  infants (64). Louik et al 
studied the prevalence of hyperglycemia in preterm infants admitted     
in   the   (NICU)   receiving   infusions  of   dextrose  10%.  
 
Hyperglycemia related to 10% dextrose solution was detected in 
(05.5%) of the infants (63). These differences could be due in part to the 
variations in the methods employed, together with the difference in the 
definitions used.  Consistent with the conclusions of many authors, 
glycemic derangements were more common in the first 24 hours of life 
(26, 64, 66, 76).  It is interesting to note that, no hypoglycemic event was 
reported on day III. This could be explained by the relatively fewer 
number of samples taken on that day, and by the fact that the most of 
the remaining infants in the study group have started to be fed.  
4.6.2. Correlation of Hypo and hyperglycemia with Different    
Variables 
       4.6.2.1. Correlation with Gender: 
                 Among the whole study group, hyperglycemia was more 
common among males. Sixty per cent of those affected were males as 
compared to (40%) females. This difference was statistically significant 
(P<0.001). The predilection of the condition to males could be due in 
part to the increased number of males among those who were mostly 
affected, namely (SGA) and the (ELBW) infants.  As far as this was 
concerned, no study had dealt with this issue. This male predominance, 
however needs to be more assessed and evaluated  by further studies.    
         4.6.2.2. Correlation with Birth Weight and Gestational Age: 
                 The frequency of hypoglycemia as well as hyperglycemia was 
clearly found to be inversely proportionate to the birth weights of the 
study group. This observation is well supported by the fact that fat 
accounts for only (02%) of body weight at 28 weeks of gestation but 
about 16% at term. Although fat is not itself convertible to glucose, 
mobilization and oxidation of fat reduces glucose uptake and oxidation 
(23).   Moreover, maturation of regulatory metabolic mechanisms is 
dependent on the gestational age (24).  
           Concerning  the early glycemic derangements relevant to the 
weight for gestation, infants who were small for gestation (SGA) were 
found to be mostly affected. Hypoglycemia was reported in (63.6%) of 
these infants compared to (44.0%) in (AGA) infants, and  in (20%) of 
(LGA) infants (P<0.000). This finding was consistent  with a Pakistanian 
study conducted by  Haronn Chisshti  who reported hypoglycemia  to 
have    occurred   in   (56%)   of  the  (SGA) infants  
group(42). The tendency of the (SGA) infants to have more hypo and 
hyperglycemic episodes    than   (AGA)   infants  demonstrated in this  
 
study is consistent with the findings of many authors (28,31,62).  
  4.6.2.3. Correlation With the Family and Birth History: 
                Infants born to consanguineous parents were detected to have 
the highest percentage of hypoglycemia (61.1%). That was statistically 
significant (P<0.03). Hyperglycemia was encountered in only (11.1%) of 
these infants (P=0.673). A genetic hypothesis might be looked for  to 
explain this .  
               Maternal diabetes was strongly associated with hypoglycemia 
which was documented in (55.5%) of the infants whose mothers were 
having the disease (P<0.001). This was not consistent with the findings 
of Nafisa Mohamed who studied the effects of maternal diabetes 
mellitus on the infants. She estimated hypoglycemia to occur in (05.5%) 
of the infants (77). This discrepancy could be explained by the small 
number of preterm infants in Nafisa`s study. Moreover, most of the 
infants in her study group were clinically stable.   
             Maternal   pre-medication   with   dextrose   infusions    was 
significantly associated with neonatal hyperglycemia (P<0.021).  This 
phenomenon could be explained by the data obtained by Mitanchez-
Mokhtari which suggested that proinsulin processing to insulin is partially 
defective in preterm neonates. Thus, the higher maternal concentrations 
of glucose reaching the fetus through the placenta would not provoke 
the expected insulin surge (71). Nonetheless, this needs to be further 
assessed and evaluated.  
            Taking the mode of delivery into account, the percentage of 
hypoglycemia was much higher in those who were delivered by 
emergency  caesarian  sections  than in those  delivered  by  elective 
sections (P<0.037). Similarly, hyperglycemia was observed in all (100%) 
of those who were delivered by emergency sections (P< 0.005). This 
association could be explained by fact that most of the infants delivered 
by this mode were already stressed and perinatally asphyxiated. Both 
conditions were documented in the causation of both hypo and 
hyperglycemia (63).   
            Episodes of both hypo and hyperglycemia occurred with an 
increasing frequency among the study group whenever the Apgar 
scores  were  low and  when more  resuscitative efforts  were needed  
(P<0.0001) for hypoglycemia, and (P<0.02) for hyperglycemia.This was 
consistent with the conclusions drawn from the studies conducted by   
Zanardo et al, Louik et al  and Falcão et al  ( 26, 63, 64). 
        
 
 
        4.6.2.4.Correlation with Early Clinical Problems and Progress: 
                  In this study, RDS was causally related to hypoglycemia but 
not to hyperglycemia (P<0.02). The propensity of infants with (RDS) to 
develop hypoglycemia rather than hyperglycemia, might be due in part 
to the fact that most of these patients were kept fasting. Hypoglycemia 
was more prevalent among patients who experienced hypothermia 
(66.7%). This was consistent with the findings of Andersen et al from 
Nepal who reported hypoglycemia in (57%) of those with a rectal 
temperature of <35.5OC at the time of sampling (40). In addition, 
hypothermia is well known to cause increased fuel demands (89).  
           Sepsis was found to be a statistically significant independent 
variable for hyperglycemia but not for hypoglycemia, (P<0.002) for 
hyperglycemia, and (P<0.64) for hypoglycemia. This finding was not 
consistent with the findings of Fitzgerald et al when  
they studied the metabolic effects of sepsis in preterm infants. In their 
study, no hypo or hyperglycemic events were documented in septic 
infants(51). However, these results were to be challenged putting into 
consideration the small sample size  of their study .  
          Although polycythemia is a well known risk factor for the 
development of hypoglycemia in the neonates, no significant 
association was found in this study group (85). This might be due to 
many factors. Firstly,  the small number as well as the heterogeneity 
of the cohort who manifested polycythemia. Secondly, other 
contributing factors such as birth weight and other clinical problems 
had existed.  Other clinical problems, namely (DIC) and (IVH) were 
causally related to the early glycemic derangements among the study 
group. This was as the same as what was reported in the findings of 
Hawdon, Falcão et al and Zobel et al (38,64,70).  
        4.6.2.5. Correlations with Medications and Feeding: 
                      It had been shown in this study that the administration of 
dextrose5% solution was significantly associated with a higher incidence    
for  both hypoglycemia    (P<0.009)  and   hyperglycemia  
(P<0.049), whereas administration of dextrose 10% was not. These 
results were different from the findings of  Ekblad et al , who studied the 
incidences of both hypo and hyperglycemia in relation to the 
concentration of the dextrose solution given. No statistically significant 
difference for the incidence of both hypo and hyperglycemia was 
recognized in that study (67).  Despite this, a likely postulation might be 
put forward to explain my findings. In all the infants, who were less than 
1000 g and  received dextrose 5%, this was given in intravenous 
boluses every two hours according to the policy in the (SCBU). In most 
instances, as noticed by the author, these boluses were administered 
rapidly thus delivering large amounts of glucose to these tiny babies. 
The immediate response would be hyperglycemia which would in turn 
provoke insulin secretion. The end result of this cascade would be 
rebound hypoglycemia (88). Considering this, some authors argued that 
there is no place for treatment with intermittent glucose boluses alone 
for the preterm infants (56). 
          Administration of aminophylline was significantly associated with 
hyperglycemia  among the   study group  (P<0.03).  This was the  
conclusion arrived at in a similar study carried out  by Howden     et al 
(68). Delayed feeding was found to be associated with hypoglycemia 
significantly (p <0.047). For similar reasons, the (WHO) had 
recommended early feeding to all neonates especially the high risk ones 
like preterm and (SGA) infants (1) .                          
   
 
 
  4.6.3. Correlation of the Glycemic Derangements with the 
               Patterns of Outcome of the Study Group:         
             Hypoglycemia was reported during the course of (64.3%) of the 
infants who died (P<0.001). Hyperglycemia occurred less frequently 
among those who died and was observed in (42.9%) of that cohort 
(P<0.025). Whether these glycemic derangements were contributory 
factors in the deaths, or whether they were the effects of other problems 
more studies are needed to elaborate on this. Nevertheless, it can be 
strongly convincing that hypo and hyperglycemia were both poor 
prognostic indicators for the survival of preterm infants . 
4.7. THE MAGNITUDE OF THE PROBLEM. 
          Early glycemic derangements were quite common among preterm 
infants especially in our situation  where the resources are limited and 
the  facilities are poor. Among preterm infants admitted in the special 
care bay unit in Omdurman Maternity Hospital, hypoglycemia was 
detected in (46.8%). An additional (24.4%) experienced hyperglycemia. 
These abnormalities were mostly seen during the first 24 hours.  
          Hypoglycemia can have deleterious effects in the short term as  
well as later in life. The poor late neurodevelopmental  sequelae  of 
hypoglycemia are well recognized (38). On the other hand, hyperglycemia 
is associated with increased morbidity and mortality. It can acutely 
cause cerebral oedema, osmotic diuresis and consequent 
dehydration(2,65). Moreover, its management  encompasses a real 
challenge to the physicians especially where the facilities for insulin 
pumps and monitoring are lacking (74). Therefore, it always seems wise 
to take these glycemic abnormalities into consideration in every single 
newborn preterm infant.  
           The special care baby unit (SCBU) at Omdurman Maternity 
Hospital, though it served a large population, has many problems. 
Inadequate staffing and equipment, overcrowding, limited recourses 
and poor facilities are amongst these problems. Accordingly, the 
mortality rates are high. The condition in other peripheral states, 








• Glycemic derangements were commonly encountered in newborn 
preterm infants admitted in the special baby care unit in 
Omdurman Maternity Hospital, Sudan, during the first 72 hours of 
life.  
• Early hypoglycemia was found in (46.8%) of the study group, while 
early hyperglycemia was as frequent as (24.4%) among the study 
group.  
• The first 24 hours of life were the most critical period during which 
most of the hypo and hyperglycemic episodes were reported. 
Thereafter, steady decline in the incidences occured.  
•   Among the whole study group, hyperglycemia was more common 
among males. The male to female ratio was estimated to be 1.5:1. 
• The frequency of hypoglycemia and hyperglycemia was clearly 
found to be inversely proportionate to the birth weights as well as 
the gestational age of the study group. 
• Hypoglycemia was detected in (63.6%) of the (SGA) infants, whilst 
hyperglycemia was seen in  (36.6%). 
• Parents consanguinity and maternal diabetes were associated 
with a significant risk of neonatal hypoglycemia. Other maternal 
medical and obstetrical problems were not associated with 
glycemic derangements in the newborns. 
• Factors which were found to be associated with hyperglycemia 
were; maternal pre-medication with dextrose infusion, delivery by 
(EMCS), administration of aminophylline, intermittent dextrose 
boluses, (IVH), early sepsis, (DIC) and low Apgar score at birth. 
• Factors which were found to be significantly associated with 
hypoglycemia were; (RDS), hypothermia, intermittent boluses of 
dextrose,delayed feeding, and low Apgar score at birth. 
• The mortality rate among the study group was (34.1%). Most of 
deaths were due to respiratory distress syndrome (35.7%). 
• Hypoglycemia was reported along the course of (64.3%) of the 
infants who died. Hyperglycemia occurred less frequently among 
those who died and was observed in (42.9%) of that cohort. 
Accordingly, hypo and hyperglycemia were both found to be poor 




• Early hypo and hyperglycemic events in all preterm infants should be 
looked for and  diagnosed to avoid unnecessary complications and 
mortality. 
• Routine use of infusion pumps and microdroppers to administer 
dextrose solutions and other medications in the nursery, is strongly 
recommended in order to lessen the frequency of both hypo and 
hyperglycemia.  
• Strict monitoring of the glycemic status of  newborn preterm infants, 
specially the sick ones, in the first 24-48 hours of life, should be an 
essential component of  their management strategy in every nursery. 
•  Feeding should be started as early as the clinical condition of the 
preterm infant permits, to decrease the risk of hypoglycemia. Use of 
breast milk whenever feasible should be preferred to other types of 
food. 
• The Obstetrical Department in Omdurman Maternity Hospital is 
strongly urged to promote  the use of antenatal steroids in order to 
reduce the incidence of (RDS) and (IVH) in the preterm infants. 
 
• Preterm infants should be nursed separately  in the special care unit 
in Omdurman Maternity Hospital, as this will optimize the quality of 
care offered to these high risk infants. 
• Exogenous surfactant together with ventilatory support systems and 
arterial blood gases machines, should be made available in the 
(SCBU) since more than half of the admissions are preterm infants. 
The Federal Ministry of Health should include these issues among 
other strategies of child survival programmes.  
• Use of intermittent dextrose boluses as part of the routine 
management of (ELBW) infants should be reconsidered and 
thoroughly studied. 
• More mothers should be encouraged to be recruited in  antenatal 
care programmes through effective communication and community 
mobilization. This will notably reduce the incidence of preterm births. 
• The study calls for more studies that should address in depth the 
endocrinological, metabolic, genetic  and pathologic issues in 
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